Gefitinib (ZD1839)

Catalog No.S1025

Gefitinib (ZD1839) Chemical Structure

Molecular Weight(MW): 446.90

Gefitinib (ZD-1839) is an EGFR inhibitor for Tyr1173, Tyr992, Tyr1173 and Tyr992 in the NR6wtEGFR and NR6W cells with IC50 of 37 nM, 37nM, 26 nM and 57 nM, respectively.

Size Price Stock Quantity  
In DMSO USD 191 In stock
USD 147 In stock
USD 270 In stock

Free Overnight Delivery on orders over $ 500
Next day delivery by 10:00 a.m. Order now.

Cited by 90 Publications

11 Customer Reviews

  • Perturbation of EGFR by its ligand EGF and gefitinib (ZD-1839 Iressat; inhibits EGFR) produces opposite responses in the predicted EGFR target genes SOCS2 and NR2E1.

    Mol Syst Biol 2011 7, 486. Gefitinib (ZD1839) purchased from Selleck.

    Effects of shRNA-mediated RECK depletion on EGFR signaling in MEFs. (a) Immunoblotting (IB) of the indicated proteins in wild-type MEFs transduced with the indicated shRNAs and cultured for 48 h in the presence of 0.1% dimethyl sulfoxide (DMSO; vehicle) or 1 mM gefitinib (S1025, Selleck Chemicals,Houston, TX, USA). (b) Immunoprecipitation from whole lysates of cells from panel a with an anti-phosphorylated tyrosine (pTyr) antibody. Precipitates from 500 mg protein in whole cell lysates (upper) or 20 mg protein in whole cell lysates (lower) were analyzed by IB with anti-EGFR antibody.

    Oncogene 2010 30, 737-750. Gefitinib (ZD1839) purchased from Selleck.

  • (B–C) LNCaP (B) and LNCaP-AI (C) cells were transiently transfected with sPLA2-IIa(-800)-Luc (0.5 μg). The cells were then treated with Erlotinib (20 μM), Gefitinib (20 μM), Lapatinib (20 μM), CI-1033 (8 μM), LY294002 (20 lM) and Bortezomib (20 μM) without or with EGF (100 ng/ml) for 24 h. Luciferase assay was performed according to a standard protocol with Renilla luciferase as an internal control. Data are presented as the mean (±SD) of duplicate values of a representative experiment that was independently repeated for five times.

    Carcinogenesis 2010 31, 1948–1955 . Gefitinib (ZD1839) purchased from Selleck.

    LNCaP-AI cells were starved in 1% stripped medium for 24 h. The cells were then treated with Erlotinib (20 μM), Gefitinib (20 μM), Lapatinib (20 μM), CI-1033 (8 μM), LY294002 (20 μM) and Bortezomib (20 μM) for 24 h. Cell culture medium was collected from each sample and subjected to ELISA for sPLA2-IIa. The condition medium samples were diluted 10 times for ELISA. Average of duplicate samples was converted to nanogram per milliliter against standard curve. The data represent one of five repeated experiments.

     

     

    Carcinogenesis 2010 31, 1948–1955. Gefitinib (ZD1839) purchased from Selleck.

  • Susceptibility of lung cancer cells to cytolytic activity of NK-92 cells after treatment with EGFR inhibitors. Three lung cancer cells were untreated (open circle) or treated with 10 μM erlotinib or gefitinib (black filled square or black filled triangle) for 24 hours. The lung cancer cells were cocultured with NK-92 cells at indicated effector to target ratio (E:T ratio). To determine the specificity of NKG2D-mediated cytolysis of lung cancer cells, NK-92 cells were preincubated with blocking mAb against NKG2D before the assay (gray filled square and triangle) and correspond-ing isotype mAb (open square and triangle).

    J Immunother 2011 34(4), 372-81. Gefitinib (ZD1839) purchased from Selleck.

    Suppression of EGFR signaling by Gefitinib is dose dependent and non- toxic at millimolar concentrations.Results from plaque reduction tests of Hep2 cells infected with VACV(12.5pfu/well) treated with a serial dilution of Gefitinib (1000-0.01 m) and analyzed for (A)proliferation as indicator of cytotoxicity,(B) IC50 of plaque size inhibition, (C)dose dependent inhibition of EGFR-ERK1/2signaling and VACV proteins by Western blot analysis (pEGFR detection was obtained from a different experiment with identicals ettings) and (D)dose dependent inhibition of orthopoxvirus genome replication by real-time PCR.Untreated VACV infectedcells and uninfected cells are shown as controls in the right panel.

    Antiviral Res 2010 89, 64-70. Gefitinib (ZD1839) purchased from Selleck.

  • A circular zone of EGFR activated but uninfected cells facilitate virus induced plaque development , efficiently blocked by Gefitinib. (A)Immun of luorescent staining of aplaque reduction tests with Hep2 cells 24,48,72 and 96 h after VACV infection (6.25pfu/chamber). VACV infected cells(green) were visualized by human IgG directed to orthopoxviruses (VIG) detected with a secondary FITC labelled antibody. Uninfected cells with activated EGFR signaling(red) are detected with a secondary Cy3labelled antibody. Positive cells for both , VACV and phosphorylated EGFR are shown in yellow(merge). Cellular nuclei are counterstained with DAPI. (B)Immunofluorescent staining of a plaque reduction test as described for (A) and treated with three different Gefitinib concentrations (1000 nM, 1 nM, and 0.01 nM) . The test was analyzed 96h afterVACV infection.Uninfected cells are shown as controls. Magnification100×.(For interpretation of the references to color in this figure legend , the reader is referred to the web version of the article.)

     

     

    Antiviral Res 2010 89, 64-70. Gefitinib (ZD1839) purchased from Selleck.

    The EGF-dependent increased association of PCM1 and AZI1 requires EGFR kinase activity. ZD1839 (Iressa)—EGFR tyrosine kinase inhibitor.

    Mol Biosyst 2011 7, 3223-33. Gefitinib (ZD1839) purchased from Selleck.

  • Inhibition of signaling pathway activation in lung tumor cell lines by kinase inhibitors. Lung tumor cells were cultured in 10% FBS until reaching ∼80% confluence and then the cells were starved in serum-free medium for overnight, followed by 4-hour treatment with the inhibitors. Cell lysates were then prepared and used for determination of the pathway activation signals by the CEER assay.

    Int J Proteomics 2011 215496. Gefitinib (ZD1839) purchased from Selleck.

    Breast cancer cells were pretreated with 100ng/ml EGF for 15 min and then treated with the indicated concentrations of  Gefitinib for 24 hours.

     

     

    2010 Dr. Zhang of Tianjin Medical University. Gefitinib (ZD1839) purchased from Selleck.

  • MTT assay result. 0-500nM Gefitinib treated with H1299, H358, H25 and HCC827 cell lines by 72h, Proliferation rate was tested.

     

     

    2010 Dr. Vicky Tin from University of Hong Kong. Gefitinib (ZD1839) purchased from Selleck.

Purity & Quality Control

Choose Selective EGFR Inhibitors

Click to view more

Notes:

2. For more details, such as half maximal inhibitory concentrations (IC50s) and working concentrations of each inhibitor, please click on the link of the inhibitor of interest.
3. "+" indicates inhibitory effect. Increased inhibition is marked by a higher "+" designation.
4. Orange "√" refers to compounds which do inhibitory effects on the related isoform, but without specific value.

Biological Activity

Description Gefitinib (ZD-1839) is an EGFR inhibitor for Tyr1173, Tyr992, Tyr1173 and Tyr992 in the NR6wtEGFR and NR6W cells with IC50 of 37 nM, 37nM, 26 nM and 57 nM, respectively.
Features A potent EGFR tyrosine kinase inhibitor.
Targets
Tyr1173 (NR6W cells) [1] Tyr1173 (NR6wtEGFR cells) [1] Tyr992 (NR6wtEGFR cells) [1] Tyr992 (NR6W cells) [1]
26 nM 37 nM 37 nM 57 nM
In vitro

Gefitinib effectively inhibits all tyrosine phosphorylation sites on EGFR in both the high and low-EGFR-expressing cell lines including NR6, NR6M and NR6W cell lines. The phosphorylation sites Tyr1173 and Tyr992 are less sensitive requiring higher concentrations of Gefitinib for inhibition. Gefitinib effectively blocks the phosphorylation of PLC-γ, with IC50 of 27nM, in NR6W cells. The NR6wtEGFR and NR6M cell lines has low levels of PLC-γ phosphorylation but the level in the NR6M cell line is more resistant to inhibition by Gefitinib with IC50 of 43 nM and 369 nM, respectively. Gefitinib inhibits Akt phosphorylations, with IC50 of 220 and 263nM, in the low-EGFR- and -EGFRvIII-expressing cell lines, respectively. Gefitinib in the dose range from 0.1 to 0.5μM significantly facilitates, rather than abrogates, colony formation of NR6M cells. However, at a concentration of 2 μM Gefitinib completely blocks NR6M colony formation. Gefitinib rapidly and in a dose-dependent manner inhibits EGFR and ERK phosphorylation up to 72 hours after EGF stimulation in both the high- and low-EGFR-expressing cell lines. [1] Gefitinib is the monolayer growth of these EGF-driven untransformed MCF10A cells with an IC50 of 20 nM. [2] The combination of Gefitinib (0.2 μM and 0.5 μM) with irradiation lead to a significant growth inhibition in LoVo cells, compared with radiation alone.. [3]

Cell Data
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
KB MYTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NGf0OWZKSzVyPUCuNFU1KM7:TR?= M17aOVE3PTF4NEez
NIH3T3 NXHHTYRGTnWwY4Tpc44hSXO|YYm= M4HENFAvOiEQvF2= NETmVFIzKGh? NHLJNFdFVVOR NFLwWHdKdmirYnn0bY9vKG:oIFXHSkB{fGmvdXzheIVlKGi3bXHuJIVz[kJzIHH1eI9xcG:|cHjvdplt[XSrb36ge4l1cCCLQ{WwJI9nKDBwMEG0OEDPxE1? MX:xOlQ5ODJ6NB?=
COS7 NH7GS4dHfW6ldHnvckBCe3OjeR?= M4G2Ulk3KM7:TR?= M3n2OGlvcGmkaYTpc44hd2ZiaIXtZY4hUkGNMjDWOlE4TiCvdYThcpQh\XiycnXzd4Vl M4fJeVE4OTd6N{Ky
A549 M3njPGN6fG:2b4jpZ{BCe3OjeR?= M134Xlk3KGh? NVrX[XJNTE2VTx?= NGTqSI1KSzVyPUGzMlU6KM7:TR?= NVHXUlZpOTh|MUO4NFc>
K562 NEXKS2NEgXSxdH;4bYMhSXO|YYm= MWC5OkBp MUHEUXNQ MVzJR|UxRTlwM{[g{txO MoW0NVg{OTN6MEe=
MDA-MB-231 MYHDfZRwfG:6aXOgRZN{[Xl? MkLMPVYhcA>? NYHiPGoyTE2VTx?= MUjJR|UxRTN4Lk[xJO69VQ>? Mon5NVg{OTN6MEe=
MOLT4 MU\DfZRwfG:6aXOgRZN{[Xl? NHjPZpQ6PiCq MoXMSG1UVw>? NYnlUIhiUUN3ME2xOU4xOiEQvF2= M4XJSFE5OzF|OEC3
MCF7 MV\DfZRwfG:6aXOgRZN{[Xl? NHHDTlQ2OCEQvF2= NETQOIY4OiCq Mn7FTWM2OD1zMj6wOUDPxE1? M{m5V|E5PzdzOEG5
BT474 MWnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MUW3NkBp MYDBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IHj1cYFvKEKWNEe0JINmdGy|IH;2[ZJmgHC{ZYPzbY5oKEWUQnKyJJdqfGhiRVO1NEBw\iByLkOg{txO NUKxfWZCOTlyMki0NlQ>
HN5 MVfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NIP0Wo44OiCq NUHSe3k2SW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDIUlUh[2WubIOgc5ZmemW6cILld5NqdmdiRVfGVkB4cXSqIFXDOVAhd2ZiMD6wNUDPxE1? MVWxPVAzQDR{NB?=
BA/F3 MX\DfZRwfG:6aXOgRZN{[Xl? Mmj0O|IhcA>? NVTPXnJFS3m2b4TvfIlkcXS7IHHnZYlve3RibX;1d4UhSkFxRkOgZ4VtdHNiZYjwdoV{e2mwZzDFS2ZTKEx6NUjSJI12fGGwdDD3bZRpKEmFNUCgc4YhOC5yMUC4JO69VQ>? MX2xPVI{QTJ{OR?=
NIH3T3 MnvUS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NWDnb4k1PzJiaB?= NHLre2JIem:5dHigbY5pcWKrdHnvckBw\iCvb4Xz[UBPUUhxM2SzJINmdGy|IHX4dJJme3Orbneg[ZJDOiCpZX7lJJdqfGhiSVO1NEBw\iByLkW0JO69VQ>? NH\WUWkyQTZ4NUO3Oy=>
MCF7 MX MkDrSpVv[3Srb36gRZN{[Xl? NVTQWpZpOzBibXnu NUDNd4lYUW6qaXLpeIlwdiCxZjDCR3JRKGW6cILld5Nm\CC5aYToJGlEPTBib3[gNU4yKM7:TR?= NUnjSW9MOTl7M{K5OlA>
A431 M125[Wdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NIe3R3oyOCEQvF2= NFXWW4E4OiCq MoTBS2k2OD1yLkWxOEDPxE1? NUX2WXRjOTl7Nkm0OlU>
A431 Mk[5T4lv[XOnIFHzd4F6 M4DjU|AvOSEQvF2= MUWxJIg> NVruNXRGUW6qaXLpeIlwdiCxZjDFS2YucW6mdXPl[EBGT0[UIIDoc5NxcG:{eXzheIlwdg>? MlTCNVk6Pjl2NkW=
A431 NUTGNHJoU2mwYYPlJGF{e2G7 NEPKTIUyODBizszN MVixNEBucW5? NGPMfolRem:ub37n[YQhcW6qaXLpeI9zgSCjY4Tpeol1gSCxZjDFS2YucW6mdXPl[EBGT0[UIIDoc5NxcG:{eXzheIlwdg>? Moq1NVk6Pjl2NkW=
Sf9 M2ftWWtqdmG|ZTDBd5NigQ>? MYSxNEBucW5? MYjEUXNQ M3u3WGlvcGmkaYTpc44hd2ZiRVfGVkBmgHC{ZYPz[YQh[XO|ZYPz[YQh[XNiaX7obYJqfGmxbjDv[kBz\WOncITvdkBifXSxcHjvd5Bpd3K7bHH0bY9vKHerdHigTWM2OCCxZjCwMlA{OyEQvF2= NY\6OWExOjByNU[0NlU>
NCI-H1975 NF\rcpVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MV61JO69VQ>? NUT5VoozPzJiaB?= M4PONWlEPTB;OD6yOkDPxE1? MoG5NlAyPTF4N{C=
NCI-H1975 M1Poc2tqdmG|ZTDBd5NigQ>? M1nlSVExKM7:TR?= NInMT2pKdmirYnn0bY9vKG:oIFXHSnIh[XW2b4Doc5NxcG:{eXzheIlwdg>? NI\nU24zODF3MU[3NC=>
NCI-H1975 NV3WPXhnTnWwY4Tpc44hSXO|YYm= NYHyeI05OTBizszN NV;ZZWh4UW6qaXLpeIlwdiCxZjDFVmJDOiCjdYTvdIhwe3Cqb4L5cIF1cW:w NWi2TnVzOjBzNUG2O|A>
NCI-H1975 M1\oVWZ2dmO2aX;uJGF{e2G7 MUW1JO69VQ>? MoG2OFghcA>? Mk\MTY5lfWO2aX;uJI9nKGGyb4D0c5NqeyCjc4Pld5Nm\CCjczDhZ5RqfmG2aX;uJI9nKGOjc4Dhd4UuOw>? NFfI[I8zODF3MU[3NC=>
A375 NHHFV5hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MX:0PEBp NHLTW5FKSzVyPUKwMlU2KM7:TR?= NVnHdZpKOjB|MES1N|c>
SMMC7721 NYXBcGRrT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NV;TcopVPDhiaB?= MVzJR|UxRTN|LkGyJO69VQ>? MW[yNFMxPDV|Nx?=
DU145 MmPzR5l1d3SxeHnjJGF{e2G7 NVmzfW1mPSCm NHTDSHdFVVOR M3nBVGlEPTB;NEKuNVch|ryP NVf2fppoOjB2Nk[1OVU>
MIAPaCa2 NX;4[XJoS3m2b4TvfIlkKEG|c3H5 NEfQbHU2KGR? NE[2U|lFVVOR NFjQZ|RKSzVyPUWwMlYzKM7:TR?= NGTrXGczODR4NkW1OS=>
PANC1 M2DTXWN6fG:2b4jpZ{BCe3OjeR?= NFrue4c2KGR? NWTEdI9RTE2VTx?= NWjwOVl[UUN3ME20NE41OiEQvF2= M2fo[|IxPDZ4NUW1
PC9 MnXkS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MVnBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IFXHSnIu\GWoaXPp[Y51KGi3bXHuJHBEQSClZXzsd{B4cXSqIFXDOVAhd2ZiMD6wNVch|ryP MVKyNVIxQDhyMh?=
PC9 M1PMWmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NGrrTWdCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JIdzd3e2aD3y[ZNqe3SjboSgbJVu[W5iUFO5JINmdGy|IHX4dJJme3OrbnegSWdHWiCHN{S2Y2E4PTBxVEe5NG0hdXW2YX70JJdqfGhiRVO1NEBw\iB5IN88US=> NVH1cWpEOjF{MEi4NFI>
PC3 MYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NUTle|FQOTBizszN Mn31O|IhcA>? NH7KdXRFVVOR Mn3wTWM2OD15LkSg{txO NF3NUJkzOTN3M{W0Oi=>
MDA-MB-468 MXzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NFXTTpkyODBizszN MkPwOFghcA>? NXXEToo6TE2VTx?= MkS3RY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdIm= NUXRRo1ROjF2Mkm2N|I>
Plasmodium falciparum NHvjNJRyUFSVIIDyc4ZqdGmwZzDmc5IhcW6qaXLpeI9zeyCxZjDQcIF{dW:maYXtJIZidGOrcHHyeY0heHKxbHnm[ZJifGmxbh?= NEf3OokzOThzN{C0OS=>
NCI-H1993 M2Drfmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M3;JT|czKGh? M4jLV2ROW09? MlTPTWM2OD1yLkGg{txO NXHuUXJvOjF7MU[0N|M>
NCI-H292 M1jadmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NGDmWog4OiCq M1LWfmROW09? M{ntSWlEPTB;MD6wNkDPxE1? NUL6SFd[OjF7MU[0N|M>
A431 MV3LbY5ie2ViQYPzZZk> MV:yJIg> MY\EUXNQ NGjvVJJKdmirYnn0bY9vKG:oIFXHSnIheGixc4Doc5J6dGG2aX;uJIlvKEWJRj3zeIlufWyjdHXkJIh2dWGwIFG0N|Ehf2m2aDDJR|UxKG:oIECuNFAyKM7:TR?= MYGyNlExOTF|Mh?=
MCF7 NEPHUYFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NF;PbWIyODEEoN88[{9uVA>? M1LjXVQ5KGh? MlG3SG1UVw>? NVy0W5NJSW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDNR2Y4KGOnbHzzJI93\XKneIDy[ZN{cW6pIFXHSnIh\2WwZTD3bZRpKEmFNUCgc4YhOTJwMEWg{txO NIjXblUzOjFzOUGzNC=>
BT474 MXjDfZRwfG:6aXOgRZN{[Xl? NHrCV4syOCEQvF2= MVm0PEBp M3W2c2N6fG:2b4jpZ4l1gSCjZ3HpcpN1KHOncoXtMZN1[XK4ZXSgbJVu[W5iQmS0O|Qh[2WubIO= MmfPNlIyOzh|MEi=
MCF7 NYTYbW5nS3m2b4TvfIlkKEG|c3H5 NFHjXlAyOCEQvF2= MWW0PEBp NV3NfoExS3m2b4TvfIlkcXS7IHHnZYlve3Ric3XyeY0ue3Sjco\l[EBpfW2jbjDNR2Y4KGOnbHzzJI93\XJvZYjwdoV{e2mwZzDFdoJDOiClZXzsdy=> NXvBVVhqOjJzM{izNFg>
HCC827 NW\2[5NrU2mwYYPlJGF{e2G7 NIPSdoIxNjF{NTFOwG0> NFXLbFczPCCq MUHEUXNQ NGPkbZVKdmirYnn0bY9vKG:oIFXHSnIh\GWuIFW3OFYuSTd3MDDteZRidnRiWUGwOlgh[XW2b4Doc5NxcG:{eXzheIlwdg>? M3e5TFIzOzN7M{Sy
HCC827 NWPpR481U2mwYYPlJGF{e2G7 MnHpNE4yOjVizszN M4XhclI1KGh? M3vsbmROW09? NYLwO|I3UW6qaXLpeIlwdiCxZjDFS2ZTKGSnbDDFO|Q3NUF5NUCgcZV1[W62LX3l[IlifGWmIFXyb{BxcG:|cHjvdplt[XSrb36= NF[5W4czOjN|OUO0Ni=>
HCC827 MYHLbY5ie2ViQYPzZZk> NVW1[5diOC5zMkWg{txO NEnHZo4zPCCq MY\EUXNQ MVTJcohq[mm2aX;uJI9nKEWJRmKg[IVtKEV5NE[tRVc2OCCvdYThcpQudWWmaXH0[YQhSWu2IIDoc5NxcG:{eXzheIlwdg>? MX[yNlM{QTN2Mh?=
A431 MVvLbY5ie2ViQYPzZZk> NVK5NVRDOTByIN88US=> MXuzNEBucW5? MYHJcohq[mm2aX;uJI9nKEWJRmKg[IVzcX[nZDDmdo9uKGi3bXHuJGE1OzFiY3XscEBu\W2kcnHu[UBie3Onc4Pl[EBieyCrbnjpZol1cW:wIH;mJJBwdHlvR3z1MXR6eiCyaH;zdIhwenmuYYTpc44hf2m2aDDJR|UxKG:oIEGuNFgh|ryP M3rHPVIzPjl6N{iy
H460 M3zhSGN6fG:2b4jpZ{BCe3OjeR?= MX[3NkBp MmTBTWM2OD13LkW5JO69VQ>? NHrE[5UzOjd{N{S0PS=>
HT-29 MlTXR5l1d3SxeHnjJGF{e2G7 M1v4elczKGh? MmjITWM2OD1|LkO2JO69VQ>? MnPmNlI4Ojd2NEm=
SGC7901 NXfBW|JqS3m2b4TvfIlkKEG|c3H5 NWTjVGxJPzJiaB?= NH30b4xKSzVyPUGwMlI3KM7:TR?= NH7jUnEzOjd{N{S0PS=>
A498 Ml7lS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MY\BcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IHj1cYFvKEF2OUigZ4VtdHNiZYjwdoV{e2mwZzDFS2ZTKGGwZDDTVmMhf2m2aDDJR|UxKG:oIEiuOkDPxE1? MWiyNlgyQDh2OB?=
Calu3 NVvXRZN6S3m2b4TvfIlkKEG|c3H5 NVfzUJh[OTBizsznM41N NXL6UmduPzJiaB?= NWHqZlRNUUN3ME2xMlYh|ryP M2\JSlI{OTF4MU[4
FADU MVvDfZRwfG:6aXOgRZN{[Xl? NHj2fVIyOCEQvHevcWw> MU[3NkBp M4[5dGlEPTB;MD6wOUDPxE1? MVKyN|EyPjF4OB?=
HCC827 MV\DfZRwfG:6aXOgRZN{[Xl? M{jSVlExKM7:Zz;tUC=> MmLSO|IhcA>? MWjJR|UxRTBwMECxOUDPxE1? NGfHUpAzOzFzNkG2PC=>
PC9 NG\5UllIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NH3yclYyOCEQvHevcWw> NG\G[GM4OiCq NYTPR4xCUUN3ME2wMlAxOTRizszN MUGyN|EyPjF4OB?=
Sf9 NXPqfppzU2mwYYPlJGF{e2G7 NWTYOJhIOSCq NInM[I1FVVOR NX2zWXRPUW6qaXLpeIlwdiCxZjDoeY1idiCJU2SteIFo\2WmIFXHSnIhVDh|NGKgcZV1[W62IHX4dJJme3OnZDD3bZRpKEmFNUCgc4YhOC5yMUWg{txO NIXZblUzOzZzMU[5NS=>
16HBE14o- Mln3R5l1d3SxeHnjJGF{e2G7 NHnqbJUyOCEQvF2= NXTMelhiPzJiaB?= MmH5SG1UVw>? MXrDfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjCxOmhDTTF2bz2gZ4VtdHNiaHHyZo9zcW6pIIfpcIQhfHmyZTDFS2ZTKGG|c3Xzd4VlKGG|IHfyc5d1cCCrbnjpZol1cW:wIIfpeIghUUN3MDDv[kAyOi55MTFOwG0> MV6yN|Y3QDR2MR?=
NCI-H1975 Ml[4R5l1d3SxeHnjJGF{e2G7 MUexNEDPxE1? NFjOU2w4OiCq NUm4TXVFTE2VTx?= MYXDfZRwfG:6aXPpeJkh[WejaX7zeEBo\W[rdHnubYIuemW|aYP0ZY51KGi3bXHuJG5EUS2KMUm3OUBk\WyuczDoZZJjd3KrbnegSWdHWiCOOEW4Vk9VPzlyTTDkc5VjdGVibYX0ZY51KGG|c3Xzd4VlKGG|IHfyc5d1cCCrbnjpZol1cW:wIIfpeIghUUN3MDDv[kA3NjlzNzFOwG0> NGC5TJozOzZ4OES0NS=>
16HBE MUfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M1XubFczKGh? MYHEUXNQ M4TRVmFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iMU\IRmUh[2WubIOg[ZhxemW|c3nu[{B4cWymIIT5dIUhTUeIUjD3bZRpKEmFNUCgc4YhOS54MEGg{txO NEHVXmozOzd7MkOxPC=>
16HBE NF6xR|FHfW6ldHnvckBCe3OjeR?= MVmxNFAh|ryP NXi4TFNROTVyIH3pci=> NXrZ[FZlTE2VTx?= Mn7yTY5lfWO2aX;uJI9nKG6rdILpZ{BwgGmmZTDwdo9lfWO2aX;uJIlvKGi3bXHuJFE3UEKHIHPlcIx{KGW6cILld5Nqdmdid3ns[EB1gXCnIFXHSnI> MX6yN|c6OjNzOB?=
A549 MY\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NGm5[G44OiCq NUHZUphNTE2VTx?= NV7xWnlXSW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEB4cWymIIT5dIUhTUeIUj;rMXJieyCmZYDlcoRmdnRiaIXtZY4hSTV2OTDj[YxteyC5aYToJGlEPTBib3[gOE43OjZizszN NF3rRoszOzd7MkOxPC=>
SH-SY5Y NEHje4REgXSxdH;4bYMhSXO|YYm= NXrq[YRqPzJiaB?= MWHJR|UxRTF6LkKxJO69VQ>? MWWyN|g4OTlyOR?=
LoVo M3vDZmtqdmG|ZTDBd5NigQ>? MYqyJEBp MmHUSG1UVw>? NX20[mdQUW6qaXLpeIlwdiCxZjDFS2ZTKHCqb4PwbI9zgWyjdHnvckB4cXSqIFnDOVAhd2ZiMD6wOlIh|ryP NX[4UmNkOjN7M{C5PVQ>
PC9 NEHNd3FMcW6jc3WgRZN{[Xl? MXKyJIg> MWfEUXNQ MmLITY5pcWKrdHnvckBw\iCHR1\SJIV5d25iMUmg[IVt\XSrb36gZYN1cX[jdHnu[{BufXSjboSgdIhwe3Cqb4L5cIF1cW:wIHnuJIh2dWGwIGDDPUBk\WyuczD3bZRpKEmFNUCgc4YhOC5yMEi3JO69VQ>? M3zQRVI{QTNyOUm0
HCC827 MV3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MV[3NkBp NHLZV2NKSzVyPUCuNFEzKM7:TR?= NFPyOoMzOzl5M{G2PC=>
A549 NWPpZ3hJU2mwYYPlJGF{e2G7 M13Y[|Eh|ryP MUmxJIg> M2PDd2ROW09? MUTJcohq[mm2aX;uJI9nKEWJRmKgZZV1d3Cqb4PwbI9zgWyjdHnvckB4cXSqIFnDOVAhd2ZiMD6wN|k6KM7:TR?= MUOyN|k5QDN3NB?=
A549 MmixSpVv[3Srb36gRZN{[Xl? MX:xJO69VQ>? NV\hTZRGOSCq M{m0[2ROW09? NXHOTnc4S2WubIXsZZIhfXC2YXvl NF;oRpYzOzl6OEO1OC=>
HCC827 MmThT4lv[XOnIFHzd4F6 NXvhdXU{OC53IN88US=> M4rENlIhcA>? NUH3RmlQTE2VTx?= M4rTWmlvcGmkaYTpc44hd2ZiRVfGVkBxcG:|cHjvdplt[XSrb36gbY4h\2WoaYTpcoljNXKnc3nzeIFvfCCqdX3hckBJS0N6MkegZ4VtdHN? NWPGW4VEOjN7OUOzNlg>
HCC827 NHHpbpVHfW6ldHnvckBCe3OjeR?= M{i2SlAvPSEQvF2= NIH2W3MzKGh? NED6SFBFVVOR M3XnZWlvcGmkaYTpc44hd2ZiYz3N[ZQheGixc4Doc5J6dGG2aX;uJIlvKGenZnn0bY5q[i2{ZYPpd5RidnRiaIXtZY4hUEOFOEK3JINmdGy| MYCyN|k6OzN{OB?=
HCC827 MoryS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MWCxNEDPxE1? M1;5d|czKGh? NHHHblJFVVOR NFzPcXZCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JIdm\mm2aX7pZk1{\W6|aYTpeoUhcHWvYX6gTGNEQDJ5IHPlcIx{KGijcnLvdolv\yCHR1\SJGU4PDZidH:gRVc2OCCmZXzleIlwdiC5aYToJGlEPTBib3[gNE4xODV6MTFOwG0> NYHuWFczOjRyNUO2O|Q>
A431 NXzFV4E4U2mwYYPlJGF{e2G7 MlLtNVAxKM7:TR?= NFzBe4E{OCCvaX6= NVXkdJE4UW6qaXLpeIlwdiCxZjDFS2ZTKGmwIIPo[YQhdWWvYoLhcoUhfmW|aXPs[ZMhf2m2aDDJR|UxKG:oIEGuNUDPxE1? NHPPOGwzPDB7NESzNi=>
BCRP-MDCK2 NX7zfHR4TnWwY4Tpc44hSXO|YYm= M1z0U|EvQCEQvF2= NUTnbnhZPzJiaB?= MX\EUXNQ MV\JcoNz\WG|ZTDv[kBxdGG|bXGgcYVu[nKjbnWg[ZhxemW|c3nvckBw\iCEQ2LQJIV5eHKnc4PpcochemWyb4L0[ZIh\2WwZTDHSnA> NH7wWHkzPDF6NEKxNy=>
BCRP-MDCK2 NFLsN5pHfW6ldHnvckBCe3OjeR?= MX[xMlgh|ryP M13ReVczKGh? NI\pNXRFVVOR NF7zUVVT\WS3Y4Tpc44hd2ZicHzhd41iKG2nbXLyZY5mKGW6cILld5Nqd25ib3[gRmNTWCCneIDy[ZN{cW6pIILldI9zfGW{IHflcoUhT0[S MVWyOFE5PDJzMx?=
MDCK M{G1ZmN6fG:2b4jpZ{BCe3OjeR?= NEPDeXI4OiCq NXjOdVVbTE2VTx?= NUC4XlAzT0l3ME2xMlQ2KM7:TR?= M2SyWVI1OTh2MkGz
MDCK2 M1rzSGZ2dmO2aX;uJGF{e2G7 M3;lWlEvQCEQvF2= MmnTO|IhcA>? NXHYbWxjTE2VTx?= NVniSWJHUW6qaXLpeIlwdiCxZjDoeY1idiCEQ2LQJIV5eHKnc4Pl[EBie3Onc4Pl[EBieyCKb3XjbJN1KDN|M{SyJIFk[3WvdXzheIlwdiC5aYToJGlEPTBib3[gN{4yQSEQvF2= MYKyOFE5PDJzMx?=
A431 NHrNcJNEgXSxdH;4bYMhSXO|YYm= NH7CRVg4OiCq NFS4S3dFVVOR NHfqUpdEgXSxdH;4bYNqfHliYXfhbY5{fCCqdX3hckBCPDNzIHPlcIx{KGW6cILld5NqdmdiRVfGVkB4cXSqIFnDOVAhd2ZiMD61OUDPxE1? MYSyOFQyOTF{Mx?=
Calu3 NYD4fYxwS3m2b4TvfIlkKEG|c3H5 M4rNNVczKGh? NYTNV5N5TE2VTx?= Ml3CR5l1d3SxeHnjbZR6KGGpYXnud5QhcHWvYX6gR4FtfTNiY3XscJMh\XiycnXzd4lv\yCKRWKyJJdqfGhiSVO1NEBw\iByLkm5JO69VQ>? NIPudXMzPDRzMUGyNy=>
KB MnHTT4lv[XOnIFHzd4F6 NI\3b5EyOCEQvF2= M{iyZlEhcA>? NYnaRXExTE2VTx?= M1TjPWlvcGmkaYTpc44hd2ZiRVfGMZN1cW23bHH0[YQh[XW2b4Doc5NxcG:{eXzheIlwdiCxZjDFS2ZTKHerdHigTWM2OCCxZjCwMlAzPSEQvF2= NHLTUpQzPDRzMUGyNy=>
BEAS2B MYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MXG1NEDPxE1? M3z3TlczKGh? Mne2SG1UVw>? NHTU[JNKSzVyPUGzMlk1KM7:TR?= Moq1NlQ3ODd3OUG=
NCI-H1975 NWP4e5ljTnWwY4Tpc44hSXO|YYm= NXLpOGRkOTByIN88US=> MYSxOVAhdWmw M3Xy[2ROW09? MlTVTY5lfWO2aX;uJI9nKE6RIIDyc4R2[3Srb36gbY4hcHWvYX6gUmNKNUhzOUe1JINmdGy|IHjhdoJwemmwZzDFS2ZTKEx6NUjSM3Q4QTCPIH31eIFvfA>? MUWyOFYxPzV7MR?=
Hela M3HQbGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MoHiNlQhcA>? MYfEUXNQ MUnJR|UxRTJwNkeg{txO NF;ST5EzPDd|MUK4NS=>
HepG2 NXrseVJiT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NI\iN2EzPCCq NH7kW3NFVVOR NIC4fVZKSzVyPU[uOFIh|ryP Mk\4NlQ4OzF{OEG=
Sf9 Mke1T4lv[XOnIFHzd4F6 NWe0Ool7OTBibXnu NH\EcI1FVVOR MoDaTY5pcWKrdHnvckBw\iCjdYTvdIhwe3Cqb4L5cIF1cW:wIH;mJJJm[2:vYnnuZY51KGircz30ZYdo\WRiRVfGVkAp[W2rbn:gZYNq\CB4NEWtNVE5PiliZYjwdoV{e2WmIIfpeIghUUN3MDDv[kAxNjB{IN88US=> M3e4XVI1PzNzMkix
SW620 MVrDfZRwfG:6aXOgRZN{[Xl? MlfpOFghcA>? MkTRSG1UVw>? NWHKfY1MUUN3ME2yPE4zKM7:TR?= NGrwfHAzPDlyMEW5OC=>
HCC827 NUfJXplvTnWwY4Tpc44hSXO|YYm= MkXpNE42KM7:TR?= M13RZVIhcA>? M3\tOWROW09? MoOw[I9meyCwb4SgbY5pcWKrdDDjMW1mfCCjc4Pld5Nm\CCjczDpcohq[mm2aX;uJI9nKEGNVDDwbI9{eGixconsZZRqd25? MVmyN|k6OzN{OB?=
HCC827 NXTjWGU{TnWwY4Tpc44hSXO|YYm= MXuwMlUh|ryP NGCyUVgzKGh? NVjicFRlTE2VTx?= MXjkc4V{KG6xdDDpcohq[mm2IHOtUYV1KGG|c3Xzd4VlKGG|IHnubIljcXSrb36gc4YheDR2L{SyJJBpd3OyaH;yfYxifGmxbh?= MWCyN|k6OzN{OB?=
HCC827 M3:yVmN6fG:2b4jpZ{BCe3OjeR?= Mn;VNE42KM7:TR?= NWrwXFRiPzJiaB?= M4DFR2ROW09? MX\oZZMhdm9iY4n0c5RwgGmlaYT5 NYPoUIY3OjN7OUOzNlg>
NCI-H1975 NXr0dpdSTnWwY4Tpc44hSXO|YYm= NESyWnEyOCEQvF2= MWS4JIg> MXfEUXNQ NUPHdmZt\G:nczDuc5QhcW6qaXLpeIkhTUeIUjDhd5Nme3OnZDDhd{Bz\WS3Y4Tpc44hcW5iRWLLJJBpd3OyaH;yfYxifGmxbh?= M320VFI{OTF4MU[4
A431 NIfxbXhMcW6jc3WgRZN{[Xl? MlTENUDPxE1? M2XvNFEhcA>? NVHlc25JTE2VTx?= NH3ING5p[XNibn:gbZJz\X[ncoPpZoxmKGmwaHnibZRqd25ib3[gSWdHWiCjdYTvdIhwe3Cqb4L5cIF1cW:w NEDrOpUzPDlyMEW5OC=>
LNCaP M2qzemZ2dmO2aX;uJGF{e2G7 NYHWO4F5OTBizszN NWLlcWRXOmhib4KgOEBp MXXEUXNQ NGHSZ2Fld2W|IH7veEBqdmirYnn0JIF2fG:yaH;zdIhwenmuYYTpc44hd2ZiaX3teY5weHW{aX\p[YQh\myjZz30ZYdo\WRiQn34JIF{e2W|c3XkJIF{KGmwY3;ydI9z[XSrb36gc4YhYzN{UG3BWHA> NIPtNpcyQDZ4N{OxNi=>
H1975 MUDLbY5ie2ViQYPzZZk> MUSxJO69VQ>? NEPpOmMzPCCq NH7WO|ZFVVOR M{PyNYRw\XNibn;0JIlvcGmkaYSgSWdHWiCyaH;zdIhwenmuYYTpc44hcW5iaIXtZY4hUDF7N{WgZ4VtdHNiaHHyZo9zcW6pIFXHSnIhVDh3OGKvWFc6OE1ibYX0ZY51 MljWNlQ3ODd3OUG=
H1975 MUPGeY5kfGmxbjDBd5NigQ>? Mli2NUDPxE1? MlW4NlQhcA>? MWrEUXNQ NV\WdpBn\G:nczDuc5QhcW6qaXLpeEBGWkticHjvd5Bpd3K7bHH0bY9vKGmwIHj1cYFvKEhzOUe1JINmdGy|IHjhdoJwemmwZzDFS2ZTKEx6NUjSM3Q4QTCP M4HrcVI1PjB5NUmx
HCC827 NEK2XXRMcW6jc3WgRZN{[Xl? M1PkbVAvOTFizszN NET2PXoyKGh? MlX3SG1UVw>? MYToZZMhdm9iaYLy[ZZmenOrYnzlJIlvcGmkaYTpc44hd2ZiRVfGVkBie3Onc4Pl[EBieyC{ZXPveoVzgSCxZjDFS2ZTKGG3dH;wbI9{eGixconsZZRqd25? NYfG[pduOjRzMkS4PVg>
H1975 M1u1XWtqdmG|ZTDBd5NigQ>? MlW1NE4{OyEQvF2= MX[yJIg> Mmn5SG1UVw>? MYLkc4V{KG6xdDDpcohq[mm2IFXHSnIhVDh3OGKvWFc6OE1iZH;1ZoxmKG23dHHueEBie3Onc4Pl[EBieyC{ZXT1Z5Rqd25iaX6gRWtVKHCqb4PwbI9zgWyjdHnvci=> MlrHNlQyOjR6OUi=
H1975 MYTLbY5ie2ViQYPzZZk> Mn\RNE4{OyEQvF2= NUH4[GxHOiCq NHzhNo9FVVOR NYjlTG9p\G:nczDuc5QhcW6qaXLpeEBGT0[UIFy4OVhTN1R5OUDNJIRwfWKuZTDteZRidnRiYYPz[ZN{\WRiYYOgdoVlfWO2aX;uJIlvKEWUSzDwbI9{eGixconsZZRqd25? M2jkV|I1OTJ2OEm4
H1975 Mo\ST4lv[XOnIFHzd4F6 NULpW2Q4OC5|MzFOwG0> MVGyJIg> M17leWROW09? NEftNGJld2W|IH7veEBqdmirYnn0JGVITlJiTEi1PHIwXDd7MF2g[I92[mynIH31eIFvfCCyaH;zdIhwenmuYYTpc44> NEfxNIUzPDF{NEi5PC=>
H1975 MmnRT4lv[XOnIFHzd4F6 MmCxNE4yOjVizszN MmLwNlQhcA>? NYfpWHZmTE2VTx?= NGrFO|Zld2W|IH7veEBqdmirYnn0JGVITlJiTEi1PHIwXDd7MF2gcZV1[W62IGmxNFY5KGG3dH;wbI9{eGixconsZZRqd25? NEjJXIgzOjN|OUO0Ni=>
H1975 MYTLbY5ie2ViQYPzZZk> MorSNE42KM7:TR?= MVOyOEBp MkjpSG1UVw>? MWTkc4V{KG6xdDDpcohq[mm2IFXHSnIhVDh3OGKvWFc6OE1ibYX0ZY51NW2nZHnheIVlKEW{azDwbI9{eGixconsZZRqd25? NGryXFczOjN|OUO0Ni=>
H1975 NVX6fXBHU2mwYYPlJGF{e2G7 NHXxcIkxNjVizszN NULLcWtKOjRiaB?= M2T6N2ROW09? M1XmZoRw\XNibn;0JIlvcGmkaYSgSWdHWiCOOEW4Vk9VPzlyTTDteZRidnRvbXXkbYF1\WRiQXv0JJBpd3OyaH;yfYxifGmxbh?= NHf5dpEzOjN|OUO0Ni=>
MIAPaCa2 MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MlvqNk42KM7:TR?= MX23NkBp M2TRN2ROW09? MYLoZZMhdm9iZ4Lve5RpKGmwaHnibZRqd25? MkLyNlA1PjZ3NUW=
MIAPaCa2 NXK5fpVSS3m2b4TvfIlkKEG|c3H5 MVSxJO69VQ>? NHu0e2EyOCCm MUHEUXNQ MYPoZZMhdm9iY4n0c5RwgGmlaYT5JIF{e2W|c3XkJIF{KHO3cIDy[ZN{cW:wIH;mJINwdG:weTDmc5Ju[XSrb36= MWSyNFQ3PjV3NR?=
MIAPaCa2 NH;w[2hCeG:ydH;zbZMhSXO|YYm= MUexNEDPxE1? M3zPPVI1cCCxcjC0PEBp M4jsSWROW09? MX3kc4V{KG6xdDDpcoR2[2ViYYDvdJRwe2m| NX;LRmZuOjB2Nk[1OVU>
MIAPaCa2 NGPlS|RCeG:ydH;zbZMhSXO|YYm= MnnaNlAh|ryP MmGyNlQhcA>? MmrHSG1UVw>? Mljp[I9meyCwb4SgbY5lfWOnIHHwc5B1d3OrczDhd5Nme3OnZDDhd{Bk[XOyYYPlJFMh[WO2aY\heIlwdg>? M1W2S|IxPDZ4NUW1
EoL-1 M33jPWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NHOwWHJKSzVyPUWuNVchdk1? NE\0WmdUSU6JRWK=
NCI-H720 NFO5R3RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NXn5d4szUUN3ME2yOk46OiCwTR?= MonNV2FPT0WU
NCI-SNU-5 MX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NFjxfmhKSzVyPUK4MlE6KG6P MomzV2FPT0WU
EW-3 MYDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MkTPTWM2OD12Nj6wOEBvVQ>? NVjlNmU3W0GQR1XS
HCC2218 NWfRcGhVT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M3Pw[2lEPTB;NUCuOVkhdk1? M4HaR3NCVkeHUh?=
HuO-3N1 MWLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NWjXRYY4UUN3ME21Ok4xQSCwTR?= M4XuWnNCVkeHUh?=
DB MkHIS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MlTzTWM2OD14MD65OkBvVQ>? NIPOPZFUSU6JRWK=
HSC-4 NFv0bVFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NVK1U4t4UUN3ME22NU42OyCwTR?= NH[xZYlUSU6JRWK=
DOK MlHLS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MWDJR|UxRTl|Lk[yJI5O NIm4THZUSU6JRWK=
H9 MYDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NY\5fIlGUUN3ME2xN|cvOiCwTR?= MmjFV2FPT0WU
NCI-H292 MoPJS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NVHBb2lUUUN3ME2xOlIvPjZibl2= MXvTRW5ITVJ?
HSC-2 MVfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M4CxVGlEPTB;MU[1MlU4KG6P MUjTRW5ITVJ?
LU-65 M2rpXWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NEnMVGZKSzVyPUG2Ok43OSCwTR?= MlfGV2FPT0WU
BV-173 NXzhNZlXT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NI\MXmFKSzVyPUG4Ok42PSCwTR?= M3vPSnNCVkeHUh?=
LB2241-RCC NW\GUFJLT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NWLvTGU5UUN3ME2xPVQvQTNibl2= NXP0UoJqW0GQR1XS
KG-1 NVm4NJljT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MV3JR|UxRTJyND6zOEBvVQ>? NEf2WWxUSU6JRWK=
CHL-1 NF\6N5RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M1WxdmlEPTB;MkC4MlUyKG6P M3y1RnNCVkeHUh?=
KYSE-140 NGfQUG5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= Ml60TWM2OD1{MEmuPVYhdk1? NF\udXVUSU6JRWK=
DU-145 NYDXVoxmT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MoLYTWM2OD1{MUmuNFQhdk1? NWDQ[HFxW0GQR1XS
EW-13 M3rVbmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MoXvTWM2OD1{MkWuNUBvVQ>? Ml7DV2FPT0WU
KYSE-450 MVLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MnK5TWM2OD1{NEeuPVIhdk1? MmXSV2FPT0WU
CAL-72 MVTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MWXJR|UxRTJ4OD63N{BvVQ>? M{G3NnNCVkeHUh?=
MEG-01 M1HCZWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M{LHXGlEPTB;Mke2Mlc3KG6P MXrTRW5ITVJ?
HCE-T NVfhZ|h7T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MmjWTWM2OD1{N{muO|khdk1? MV\TRW5ITVJ?
NCI-SNU-1 M1fEWGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NWTj[5dxUUN3ME2yPFMvOzJibl2= MVfTRW5ITVJ?
CAL-27 M4TwbGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Mn;FTWM2OD1{OEmuNFghdk1? MXvTRW5ITVJ?
BALL-1 MkjVS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NVvtN4pJUUN3ME2yPVcvPDJibl2= MVHTRW5ITVJ?
SBC-1 MkTxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NH23XIdKSzVyPUOwO{44QSCwTR?= NVv6UXU3W0GQR1XS
CAL-54 MX3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MnPOTWM2OD1|MUGuNlMhdk1? M2WyU3NCVkeHUh?=
TI-73 NFi2Z5NIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NFHKU4xKSzVyPUOxNk44PSCwTR?= NV3uepVOW0GQR1XS
P12-ICHIKAWA NHH2VIhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= Mmr6TWM2OD1|MkiuNFYhdk1? NGi3cppUSU6JRWK=
ACHN NULYVWxVT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= Mo\rTWM2OD1|M{GuOEBvVQ>? NInHZ5hUSU6JRWK=
PC-14 M37HdWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MkLoTWM2OD1|M{OuOFEhdk1? M4TOOXNCVkeHUh?=
HCC1806 NIPNb5dIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NFjNPY5KSzVyPUOzO{42OSCwTR?= MU\TRW5ITVJ?
SK-MEL-24 M3;xVWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MV3JR|UxRTN|Nz64O{BvVQ>? M2\UWHNCVkeHUh?=
A4-Fuk NGm2UGJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NXz1UXZjUUN3ME2zOVAvODJibl2= NXPuW4c4W0GQR1XS
ECC10 NEjzRmNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MmPITWM2OD1|NUKuPVYhdk1? NGHoToVUSU6JRWK=
KASUMI-1 MnW2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NHfVVWxKSzVyPUO2Ok44OyCwTR?= NX2xSnV[W0GQR1XS
CAL-33 M1TlWGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NHr5THNKSzVyPUO3NE46KG6P M13IZ3NCVkeHUh?=
MDA-MB-175-VII MV;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NY\tSmRLUUN3ME2zO|gvQDhibl2= MV7TRW5ITVJ?
NUGC-3 NVLoZpBPT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= Mlv4TWM2OD12MEGuPFEhdk1? MVPTRW5ITVJ?
KY821 NGizRpZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NHHjXWJKSzVyPUSwPE42PyCwTR?= NXviOXA2W0GQR1XS
CTB-1 MmnOS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? Mn7XTWM2OD12MkSuOEBvVQ>? NFTqdmNUSU6JRWK=
DoTc2-4510 M2HpeWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NILvU2lKSzVyPUS0Nk4yOiCwTR?= NEfrd2FUSU6JRWK=
EFO-27 NIWxfnBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MYjJR|UxRTR3ND63OEBvVQ>? M3L3WHNCVkeHUh?=
BPH-1 M4jsRmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NWjnUHNZUUN3ME20PVEvOTZibl2= NYLkUZJSW0GQR1XS
KYSE-270 NWHYbnNyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MVHJR|UxRTR7OD62OUBvVQ>? M{TEO3NCVkeHUh?=
HO-1-N-1 M{TMfWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NFW3T2RKSzVyPUWwPU4zPSCwTR?= MV7TRW5ITVJ?
SK-MEL-1 MlTFS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MWfJR|UxRTVzMD65PUBvVQ>? Ml3JV2FPT0WU
MOLT-13 NFfYO25Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M4DidWlEPTB;NUG0MlgzKG6P MVXTRW5ITVJ?
TK10 NHjKXmtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NHf0[ppKSzVyPUWxOU4yOSCwTR?= MkPNV2FPT0WU
HN M33Vb2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MkLSTWM2OD13MUeuN|ghdk1? NVLPfWFjW0GQR1XS
SCC-15 M2fGW2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NXzUfm5uUUN3ME21NlUvPjhibl2= MlTnV2FPT0WU
NCI-H358 NEjuZnFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NXjoWWFZUUN3ME21NlcvPjZibl2= M334c3NCVkeHUh?=
KYSE-180 M2XDV2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M1vhfGlEPTB;NUOwMlYzKG6P M{\ReHNCVkeHUh?=
NCI-H82 MXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NGC2UHdKSzVyPUW0NE42KG6P M3fjeHNCVkeHUh?=
NB7 NV\VfJBMT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MkSzTWM2OD13NE[uN|Ihdk1? NVzoXldGW0GQR1XS
DSH1 MVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? Mk\aTWM2OD13Nk[uPFghdk1? NWT1b21wW0GQR1XS
RS4-11 NV7pU4JPT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MUnJR|UxRTV4OD61PUBvVQ>? NVXuZoZIW0GQR1XS
CAN M4nVZWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NUDzeG41UUN3ME21PFAvPzZibl2= NYnpOHN4W0GQR1XS
Ca9-22 MoTZS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? Ml;sTWM2OD13OEiuOlQhdk1? M2jRdnNCVkeHUh?=
CAL-39 MkHOS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NUTLeo5RUUN3ME21PVYvOyCwTR?= M4DTO3NCVkeHUh?=
NCI-H1623 MXXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MYXJR|UxRTV7OT6zOkBvVQ>? NYCzNlZWW0GQR1XS
FADU M13nZWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M1:4WWlEPTB;NkC0MlY6KG6P NYrL[GVbW0GQR1XS
NB69 NH\rdIlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M4nyZ2lEPTB;NkG0MlM2KG6P MVnTRW5ITVJ?
Ramos-2G6-4C10 MmThS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MmTGTWM2OD14MkGuOFYhdk1? Mlq2V2FPT0WU
LB1047-RCC M{S2Z2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NEXuRXZKSzVyPU[yOU4zQSCwTR?= M{XMU3NCVkeHUh?=
MV-4-11 NFnxSZdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MljxTWM2OD14MkeuO{BvVQ>? M3HRXXNCVkeHUh?=
DBTRG-05MG NXjUSZRlT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NH6x[G1KSzVyPU[zNk4zQCCwTR?= MVrTRW5ITVJ?
ME-180 MXHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MmPYTWM2OD14M{KuPUBvVQ>? MUHTRW5ITVJ?
NBsusSR MojnS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MkPQTWM2OD14NE[uOVIhdk1? M4rYOnNCVkeHUh?=
COR-L105 M1T0PWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NHjGS4tKSzVyPU[2Nk42OyCwTR?= MnzKV2FPT0WU
ETK-1 M{nDWmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Mn7nTWM2OD14NkKuOVkhdk1? M4T5NnNCVkeHUh?=
L-363 MXfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MV3JR|UxRTZ5MT65OEBvVQ>? M1HzWXNCVkeHUh?=
LU-134-A NFHTVYNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NH\4XlFKSzVyPUexPU4xQSCwTR?= MVnTRW5ITVJ?
NCI-H1770 M2XLRmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MXzJR|UxRTd{Mj60JI5O MX\TRW5ITVJ?
HAL-01 NF;NWWJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M2\xNmlEPTB;N{O0MlcyKG6P MkjiV2FPT0WU
COLO-684 MWHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NFfnUZFKSzVyPUe1N{4xOSCwTR?= NEe5[VVUSU6JRWK=
TE-6 M{nPUWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NVTxcoROUUN3ME23OlQvOzFibl2= MWDTRW5ITVJ?
A431 NH3BWVZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M1LqPWlEPTB;N{iwMlA1KG6P M1fDOHNCVkeHUh?=
LU-135 NUP5[pVOT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M{PRRWlEPTB;N{izMlA{KG6P NHnSTZhUSU6JRWK=
EC-GI-10 NW[zT29VT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MlnxTWM2OD15OEiuOVIhdk1? MWPTRW5ITVJ?
TE-12 NEe3OYZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MV7JR|UxRTh{MT6xNUBvVQ>? M3j0VHNCVkeHUh?=
LoVo M{X3OGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NETSNZZKSzVyPUi1PU4xPiCwTR?= NX3aeHZHW0GQR1XS
23132-87 NVvvWWtbT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MVzJR|UxRTh4ND6yPEBvVQ>? MnrxV2FPT0WU
AU565 NEixTHdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MWrJR|UxRTh4OT62JI5O NI[weZRUSU6JRWK=
DEL NWLt[3ZTT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MYfJR|UxRTh5Nz62OUBvVQ>? MmjjV2FPT0WU
COR-L88 MVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MWDJR|UxRTh6Mj6yOkBvVQ>? MoHyV2FPT0WU
NCI-H2126 M2TwVGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MmjxTWM2OD16OEKuPFMhdk1? MnXBV2FPT0WU
CAPAN-1 NVfxNJJIT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NYO5VWM2UUN3ME24PFMvOjlibl2= M1Lad3NCVkeHUh?=
BT-474 NEfHS2xIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MXnJR|UxRTl|OD6xOEBvVQ>? NIDwXG9USU6JRWK=
BHY NYn4eGlPT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NX[0SIwzUUN3ME25O|UvPDhibl2= MV3TRW5ITVJ?
HT-3 MmDPS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MXXJR|UxRTl6Mj60NUBvVQ>? MVfTRW5ITVJ?
SK-NEP-1 M1\WXGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M37s[GlEPTB;OUi5MlQ1KG6P MkOxV2FPT0WU
MS-1 MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NFrsPZZKSzVyPUm5OE43QSCwTR?= NIL1ZXlUSU6JRWK=
DOHH-2 MYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NWW4NIs1UUN3ME2xMlAxODJzIN88US=> NXzD[pExW0GQR1XS
NCI-H1304 M3rJVWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MlHhTWM2OD1zLkCxOlQ{KM7:TR?= MlLkV2FPT0WU
EM-2 MmL3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MV\JR|UxRTFwMEOwNVYh|ryP MnP2V2FPT0WU
MHH-PREB-1 MWHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MU\JR|UxRTFwMEi0OVEh|ryP MlXMV2FPT0WU
KU-19-19 NFO2cZpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NVXPemdyUUN3ME2xMlA5PTRzIN88US=> Mn7MV2FPT0WU
NCI-H1648 NWPOVYhMT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MX7JR|UxRTFwMUC2NVYh|ryP NUThOWtzW0GQR1XS
MKN1 MUPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M3rFPGlEPTB;MT6yNVk5PyEQvF2= M4rnV3NCVkeHUh?=
SNU-449 NXixWFVkT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MmCwTWM2OD1zLkKyNlA5KM7:TR?= M{DZenNCVkeHUh?=
OAW-42 M4jkXmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NIHOUIVKSzVyPUGuNlc5OjVizszN NVzXWXRTW0GQR1XS
769-P MUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MXvJR|UxRTFwMke5NVgh|ryP NHTHWWxUSU6JRWK=
SW1088 NWTK[olCT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NUHuNWRmUUN3ME2xMlI6PjB5IN88US=> NFH5NmlUSU6JRWK=
GCIY MWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NGrHN|hKSzVyPUGuN|AyOzJizszN NHTjcGtUSU6JRWK=
CTV-1 NYnQOVBHT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NHiwSJVKSzVyPUGuN|A5KM7:TR?= M3XY[3NCVkeHUh?=
NCI-H1092 NH[xNHFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NG\jS4lKSzVyPUGuN|A5PSEQvF2= Moq4V2FPT0WU
NKM-1 MYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M1fIUmlEPTB;MT6zNlU6PyEQvF2= M1HZOnNCVkeHUh?=
NCI-H1650 NIPQS|FIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MXjJR|UxRTFwM{O0PFIh|ryP NUPnUY9RW0GQR1XS
SW954 MmPVS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M{HO[GlEPTB;MT6zOFA1QCEQvF2= NIXLXZlUSU6JRWK=
SW48 NFLx[JdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MWHJR|UxRTFwM{[2NVgh|ryP M4ftRnNCVkeHUh?=
SK-N-DZ NYDGUolTT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MX7JR|UxRTFwM{[5OFch|ryP MVHTRW5ITVJ?
KMOE-2 M{K5bmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M{D4e2lEPTB;MT6zPVgyPSEQvF2= NEm1UVdUSU6JRWK=
NB5 M4e0VGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NFzxTJlKSzVyPUGuOFA5QTRizszN M16zfXNCVkeHUh?=
CCRF-CEM NG[0d4ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MULJR|UxRTFwNEGxNUDPxE1? M4\DWHNCVkeHUh?=
RH-1 M1PkU2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Mm\oTWM2OD1zLkSxNVM3KM7:TR?= NIjPbphUSU6JRWK=
NCI-H526 MmHQS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MnXQTWM2OD1zLkSzPFI3KM7:TR?= MXHTRW5ITVJ?
697 NHexSFBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NXrWbpR[UUN3ME2xMlQ1OTB2IN88US=> NVzDTXRmW0GQR1XS
J82 M{H2Umdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MoC4TWM2OD1zLkS1O|Y3KM7:TR?= MYnTRW5ITVJ?
BE-13 MUnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M4fMSWlEPTB;MT61NFY4OSEQvF2= NILXfG5USU6JRWK=
SAS M1vKVWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NVK0[ldGUUN3ME2xMlUyPjJ{IN88US=> MlnEV2FPT0WU
SCC-25 MYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NHvGfHFKSzVyPUGuOVI{OjJizszN M{HXRnNCVkeHUh?=
LAMA-84 MVfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M1:5V2lEPTB;MT61N|gyPSEQvF2= M2Gz[HNCVkeHUh?=
HSC-3 M{PE[Gdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M{LieGlEPTB;MT61OFM5KM7:TR?= M3zSZXNCVkeHUh?=
BT-549 MUXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MVXJR|UxRTFwNUi3OFch|ryP NX3IPZJ3W0GQR1XS
ML-2 Mk[4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NYOyWHBJUUN3ME2xMlY1ODJ7IN88US=> MWHTRW5ITVJ?
BB30-HNC MkjJS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NHPkWYJKSzVyPUGuOlg6PzJizszN NF:5c4hUSU6JRWK=
PANC-03-27 NEG0ZoRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NV;WNGJPUUN3ME2xMlcxOTN7IN88US=> MVvTRW5ITVJ?
COLO-678 MoHlS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NIP3b29KSzVyPUGuO|M1PDRizszN MnX4V2FPT0WU
NCI-H1666 NX7sZWk2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M{Lkd2lEPTB;MT63OFcxPCEQvF2= NWfWPHBLW0GQR1XS
NCI-H209 NIjNb2tIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MUXJR|UxRTFwN{eyOlkh|ryP MX;TRW5ITVJ?
EPLC-272H MYjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NVnvfW1{UUN3ME2xMlg2PTR7IN88US=> NYXC[5hIW0GQR1XS
OMC-1 MkLVS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M{[zfWlEPTB;MT65PVg5QCEQvF2= MoDXV2FPT0WU
HCC70 MmDuS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MnH3TWM2OD1{LkCwPFE2KM7:TR?= MkXkV2FPT0WU
CAL-12T Mnz5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M4P2dGlEPTB;Mj6wNVg3OSEQvF2= NXmyRYt1W0GQR1XS
TGBC24TKB MWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M3q2W2lEPTB;Mj6wNlk3OSEQvF2= M{SxZXNCVkeHUh?=
EKVX MYTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? Ml[1TWM2OD1{LkC0PVM6KM7:TR?= NX\qdYdLW0GQR1XS
SW1116 MlPmS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NXvoc4hVUUN3ME2yMlA3ODB7IN88US=> M3ryWXNCVkeHUh?=
NCI-H2009 NXj1W|g6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NEPWOVdKSzVyPUKuNFYzOTRizszN MU\TRW5ITVJ?
RPMI-8866 M{DNTWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M4rqcWlEPTB;Mj6wPFQ5OSEQvF2= MkfEV2FPT0WU
KARPAS-45 M2r4eWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M4jxOWlEPTB;Mj6xNlQ4QSEQvF2= NF3OVJFUSU6JRWK=
RXF393 NEPMN4JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MknVTWM2OD1{LkGzNFM3KM7:TR?= M3S4NHNCVkeHUh?=
786-0 NHPYdVRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NHzP[FhKSzVyPUKuNVg1ODZizszN MmXLV2FPT0WU
SCC-4 MmfYS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NIHBSVVKSzVyPUKuNlE4PzZizszN NWWxSYpzW0GQR1XS
BT-20 M4mzSWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MYnJR|UxRTJwMk[3OFQh|ryP MXHTRW5ITVJ?
A498 MUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MW\JR|UxRTJwMkm0NVUh|ryP MoPIV2FPT0WU
IGROV-1 NXPzd3dHT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NEfwUopKSzVyPUKuN|EzOzdizszN NXvlS4RZW0GQR1XS
JVM-3 MnvWS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NEX2b|hKSzVyPUKuN|Q3PDNizszN MkDZV2FPT0WU
NCI-H2170 MonwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MlrGTWM2OD1{LkO0O|g{KM7:TR?= Mnn4V2FPT0WU
EW-18 MnznS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MmW0TWM2OD1{LkO1OFcyKM7:TR?= M{izWXNCVkeHUh?=
KU812 MnzxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MWjJR|UxRTJwM{[3O|kh|ryP M3Hwe3NCVkeHUh?=
NY NGT4VVBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M4W2fmlEPTB;Mj6zO|I4KM7:TR?= MUDTRW5ITVJ?
HTC-C3 MYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NXqySIZiUUN3ME2yMlQzOjZ5IN88US=> NYDJWJp{W0GQR1XS
CFPAC-1 NEDQZoxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M1LO[mlEPTB;Mj60N|g3PCEQvF2= M1rOTXNCVkeHUh?=
HH M1vmZmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NHXmO2NKSzVyPUKuOFk5PTRizszN M3u2XnNCVkeHUh?=
MKN7 NW\JbG57T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MXPJR|UxRTJwNkK3OFgh|ryP M4rlcHNCVkeHUh?=
TE-8 MnzUS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NGTH[2pKSzVyPUKuOlM3PTNizszN M4PWWHNCVkeHUh?=
MC-IXC M{PKfGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MXjJR|UxRTJwNkS0OVMh|ryP NXOyR2V2W0GQR1XS
DMS-79 M4PXfmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MWnJR|UxRTJwNkmyPFQh|ryP NHfMVZBUSU6JRWK=
Detroit562 M4TWTWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M{LPPGlEPTB;Mj62PVg1PSEQvF2= NVztTGx5W0GQR1XS
HuP-T4 M3TYNGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M1zQXmlEPTB;Mj63NlgyQCEQvF2= NFzSbodUSU6JRWK=
QIMR-WIL MW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M3;xRmlEPTB;Mj63OVk2OiEQvF2= NInsbm9USU6JRWK=
BB65-RCC NHe3elFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NIG1d2ZKSzVyPUKuPFA4OTNizszN MYLTRW5ITVJ?
PC-3 MnL3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NWq4cYdrUUN3ME2yMlg{OzF5IN88US=> MVHTRW5ITVJ?
OVCAR-3 MU\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NF7zRXlKSzVyPUKuPFU2QTRizszN M{TlO3NCVkeHUh?=
KYSE-510 NFPqfVRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NIXI[WNKSzVyPUKuPFY4QDZizszN M4G5XHNCVkeHUh?=
HC-1 MWLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NITk[WZKSzVyPUKuPVQxOTJizszN MUDTRW5ITVJ?
NCI-H1693 Mn7qS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NWXLXYdqUUN3ME2yMlk2QDl5IN88US=> MlvkV2FPT0WU
DU-4475 NGT4OWtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MVrJR|UxRTJwOUmwOVIh|ryP NVTteJBHW0GQR1XS
COLO-680N NV65[WZsT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NYr1TnVtUUN3ME2zMlAxPDl3IN88US=> Mm[5V2FPT0WU
MN-60 M4nvfGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M13HOGlEPTB;Mz6wOFk4PCEQvF2= NELDRnZUSU6JRWK=
BCPAP NYL3ZlhvT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MV\JR|UxRTNwMEiyPVUh|ryP MoHhV2FPT0WU
647-V M2rDfGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NFTIU5ZKSzVyPUOuNVYzOiEQvF2= NXT5Uol4W0GQR1XS
HT-1376 NWrpSnJIT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NHrtfZpKSzVyPUOuNlA2ODZizszN NHTmZXVUSU6JRWK=
NCI-H1793 NEfBfG9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MYXJR|UxRTNwMkGwPVgh|ryP MlL0V2FPT0WU
SW1463 M1XDO2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NE\YTHdKSzVyPUOuNlYyQTJizszN NGXQbXBUSU6JRWK=
NCI-H727 MX3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? Ml;kTWM2OD1|LkO4OVg1KM7:TR?= MVjTRW5ITVJ?
LB771-HNC NEjRTW9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M2jPb2lEPTB;Mz6zPVEzPiEQvF2= MluzV2FPT0WU
D-542MG MWDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NVTOUotyUUN3ME2zMlQ1OjJ{IN88US=> NX7qWoZEW0GQR1XS
NTERA-S-cl-D1 NGXuWphIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NUj1XI1RUUN3ME2zMlQ1QTV5IN88US=> M2HJTXNCVkeHUh?=
C8166 NX\TN3h3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MWrJR|UxRTNwNE[1NlEh|ryP M1j5NnNCVkeHUh?=
639-V MYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NXu1dGw{UUN3ME2zMlU4Pzl{IN88US=> MWPTRW5ITVJ?
TE-1 MmrGS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NYPlZoJNUUN3ME2zMlU6OTZ7IN88US=> MWLTRW5ITVJ?
OAW-28 NYDnb3VVT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M3XtRmlEPTB;Mz61PVQzPiEQvF2= MmfzV2FPT0WU
SK-LU-1 M1rrOWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MoHaTWM2OD1|Lk[wOlQ2KM7:TR?= MkfYV2FPT0WU
CaR-1 NULUXoRMT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NWHa[FZ4UUN3ME2zMlYyODR6IN88US=> NWrsN5BkW0GQR1XS
A2780 M37XRmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M3jN[WlEPTB;Mz62OFA5QSEQvF2= M1HxOHNCVkeHUh?=
C2BBe1 MYnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NF3LSGtKSzVyPUOuOlQ1ODdizszN NXfQRWpnW0GQR1XS
SK-MES-1 NF70SHlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MVXJR|UxRTNwNkS2NVQh|ryP NVL3NFhYW0GQR1XS
PANC-10-05 MmW4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NFjEWFVKSzVyPUOuO|IxPzJizszN M4\6O3NCVkeHUh?=
J-RT3-T3-5 MV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MnnGTWM2OD1|Lke1OFA3KM7:TR?= M4TmXnNCVkeHUh?=
ES4 NIXDS2ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MkfyTWM2OD1|LkiyNlg3KM7:TR?= M1P1R3NCVkeHUh?=
NCI-H28 MoOwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NWPxRWl7UUN3ME2zMlgzQTZzIN88US=> NGi2[JBUSU6JRWK=
NCI-H1155 M33YW2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NGLrTWhKSzVyPUOuPFQyPTlizszN NIL2XGVUSU6JRWK=
KURAMOCHI MVfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M1vZWmlEPTB;Mz64OlA2PiEQvF2= MVHTRW5ITVJ?
NCI-H69 MnfUS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? Mn2wTWM2OD1|LkmwNVc5KM7:TR?= NFu1XlJUSU6JRWK=
IST-MES1 MonBS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NV7uXJp4UUN3ME2zMlk1ODJ7IN88US=> NX7CV4d{W0GQR1XS
NH-12 M2n4d2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M2roZ2lEPTB;Mz65OFE5PyEQvF2= M{fJe3NCVkeHUh?=
JVM-2 Mm\FS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M17BTmlEPTB;Mz65OFc2OiEQvF2= Mm\BV2FPT0WU
EW-16 NITIbVNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NELCfVlKSzVyPUOuPVU2PzdizszN NULRbnlbW0GQR1XS
NCI-H441 MYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NV\IWm5nUUN3ME2zMlk4ODF2IN88US=> MlrGV2FPT0WU
RCC10RGB M1PFdmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M4nwWWlEPTB;ND6wNVI1PiEQvF2= MnH3V2FPT0WU
TCCSUP MUXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NIr0WpVKSzVyPUSuNVExPSEQvF2= MkLYV2FPT0WU
HL-60 NImydoVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MonLTWM2OD12LkGyNlQyKM7:TR?= NILSZ2VUSU6JRWK=
EW-11 NWDjbIl7T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M4r5RmlEPTB;ND6xN|I3OSEQvF2= MlzPV2FPT0WU
KARPAS-299 MnLKS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M3rNSWlEPTB;ND6zNVAyOyEQvF2= MVPTRW5ITVJ?
SNU-C2B NV\0fnhTT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MYXJR|UxRTRwM{S2PFYh|ryP NYrSenJ4W0GQR1XS
LU-139 NF7IV41Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NHTJU2tKSzVyPUSuN|czPDdizszN M3izNXNCVkeHUh?=
HCC1937 MnnBS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M1TVPGlEPTB;ND6zO|k6OyEQvF2= NV7SNmlpW0GQR1XS
GR-ST NFHUcIlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MlG5TWM2OD12LkSzNVgh|ryP NHLGbm1USU6JRWK=
SK-OV-3 MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MUjJR|UxRTRwNE[wOFIh|ryP MkS3V2FPT0WU
A172 NWri[lhnT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M{HmfmlEPTB;ND61OVUzOSEQvF2= MUfTRW5ITVJ?
NB10 MVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NX\4emV3UUN3ME20MlU6PzhzIN88US=> M3LEU3NCVkeHUh?=
P30-OHK NV\UOGN1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M171bWlEPTB;ND64NVkzQSEQvF2= Mki3V2FPT0WU
KYSE-520 MV;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MljKTWM2OD12Lki4NFE5KM7:TR?= M1nQSHNCVkeHUh?=
KNS-62 NVjNSGVGT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NV74UYVTUUN3ME20MlkxQDB5IN88US=> MXvTRW5ITVJ?
ES1 M2rVOWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MlLzTWM2OD12Lkm2NFM2KM7:TR?= MVLTRW5ITVJ?
KOSC-2 NHvCUW5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NGD5b4pKSzVyPUSuPVk6PTlizszN NVPXU2J{W0GQR1XS
TE-9 MkDyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NFe1bVRKSzVyPUWuNFE2OjVizszN NF65eohUSU6JRWK=
NCI-H1838 M1[3fWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MojDTWM2OD13LkCyNFc3KM7:TR?= MmLmV2FPT0WU
KP-N-YN MofoS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NYi0cXpWUUN3ME21MlEzPTlzIN88US=> M17GenNCVkeHUh?=
ALL-PO NI\JOXRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NH;xNmFKSzVyPUWuNlI2QDdizszN MlHSV2FPT0WU
NOMO-1 NVL4eHlKT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NGPTV2VKSzVyPUWuNlMyPzZizszN M2r1NnNCVkeHUh?=
CGTH-W-1 MVTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NG\Wb2lKSzVyPUWuN|g2QDRizszN MYfTRW5ITVJ?
ATN-1 NXPYOIZ{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= Mmq5TWM2OD13LkSxNVg1KM7:TR?= MWrTRW5ITVJ?
AGS M{XWd2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NFrSPVdKSzVyPUWuOFk3OThizszN M1PReXNCVkeHUh?=
SW13 MmmzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M1K4PGlEPTB;NT61N|I3PSEQvF2= MXTTRW5ITVJ?
SW1990 NWnJT4U5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NUHNdHdDUUN3ME21MlYzOjh3IN88US=> MYLTRW5ITVJ?
BFTC-905 MY\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NGH4bZlKSzVyPUWuOlU5PzhizszN NHLD[2lUSU6JRWK=
RMG-I NEP5RoZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MojqTWM2OD13Lk[1PVQzKM7:TR?= MWnTRW5ITVJ?
HD-MY-Z NEm0VYlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MVPJR|UxRTVwNki1PFEh|ryP NWq2OFJ6W0GQR1XS
HCC1187 MkXMS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NHK5XVRKSzVyPUWuO|ExOzJizszN M4rTVnNCVkeHUh?=
HCC2998 NUjrbIx6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MXjJR|UxRTVwN{G4O|ch|ryP M3HjPXNCVkeHUh?=
RT-112 M2\LbGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NIDWW|ZKSzVyPUWuPVAzPDVizszN NUDvOm5zW0GQR1XS
CAKI-1 NInBSFNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MU\JR|UxRTZwMEC5PFUh|ryP M3\odnNCVkeHUh?=
HDLM-2 M3foZmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MV3JR|UxRTZwMEG0PFkh|ryP MmjIV2FPT0WU
TE-10 MWXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NFLoW|lKSzVyPU[uNFQ5OzNizszN M13Ye3NCVkeHUh?=
KE-37 M17heWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NUf0NVZJUUN3ME22MlA4OjV6IN88US=> M{jv[3NCVkeHUh?=
RCM-1 MoPkS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M4fJdGlEPTB;Nj6wO|cyQSEQvF2= MkfiV2FPT0WU
Mewo M1vNcGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MYrJR|UxRTZwMUG0PFch|ryP MonEV2FPT0WU
L-428 MlraS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NVTpZlU6UUN3ME22MlE5ODN5IN88US=> MYjTRW5ITVJ?
8-MG-BA MVPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MnqxTWM2OD14LkG5N|c6KM7:TR?= NH6xS4tUSU6JRWK=
SK-MEL-28 M3TCPGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M3f6e2lEPTB;Nj6yNFk3PyEQvF2= NUnyWXROW0GQR1XS
VA-ES-BJ M2\PW2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MYHJR|UxRTZwM{C0OlIh|ryP MYrTRW5ITVJ?
CAL-120 MoDCS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MXPJR|UxRTZwNEWxOlIh|ryP NH[2cndUSU6JRWK=
GAMG NIf6dXNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NVW2W|VsUUN3ME22MlUxPjJizszN NFXqSZRUSU6JRWK=
MSTO-221H MXLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NH\OU4lKSzVyPU[uOVEyPyEQvF2= MYPTRW5ITVJ?
GCT MWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MXfJR|UxRTZwNUOzPFch|ryP NX3UXHh2W0GQR1XS
SH-4 M3vBXGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NYrGVHM2UUN3ME22MlU5QDR2IN88US=> M375PXNCVkeHUh?=
Calu-3 MUjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NYrXNppEUUN3ME22MlY2PTZ6IN88US=> MVLTRW5ITVJ?
SK-HEP-1 MYLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NIfXSWxKSzVyPU[uO|E4PTNizszN NETnWXJUSU6JRWK=
PFSK-1 NVW2VW5oT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NYDoPWkzUUN3ME22Mlc{PDd6IN88US=> MmL0V2FPT0WU
NB12 NEKwSJZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MmXpTWM2OD14Lke4OFA1KM7:TR?= NFLLO4RUSU6JRWK=
A388 M1XsRmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MXTJR|UxRTZwOEm1NkDPxE1? NYCwN3RVW0GQR1XS
KLE M{\Gd2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MYrJR|UxRTZwOU[1NVYh|ryP NFnvSItUSU6JRWK=
TE-11 NYD5d2Y5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NHnGR5JKSzVyPUeuNFQ6PjdizszN NXPqSnJCW0GQR1XS
NCI-H2405 NYnWPYNRT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NX3OV|ExUUN3ME23MlA5Ozl|IN88US=> NFmxVIZUSU6JRWK=
OVCAR-4 NFrkTlJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= Mn:xTWM2OD15LkG1N|Uh|ryP NFfM[IhUSU6JRWK=
KP-N-YS MoXUS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MUDJR|UxRTdwMUixOEDPxE1? MVjTRW5ITVJ?
NOS-1 NIXw[WZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NVXOcpNNUUN3ME23MlI2QDJ6IN88US=> NGrI[WVUSU6JRWK=
DMS-114 MkHCS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M2HRbmlEPTB;Nz6yPVY{OSEQvF2= NX\sTm52W0GQR1XS
NCI-H2030 NH3KSoRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MonVTWM2OD15LkOzOlk5KM7:TR?= M2X0eXNCVkeHUh?=
HEL M1vrR2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MkfhTWM2OD15LkO3OVIyKM7:TR?= MmTrV2FPT0WU
CAL-62 NWf1UXRDT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M1TzUWlEPTB;Nz6zPVg3PiEQvF2= NIHISHZUSU6JRWK=
COLO-668 NYP6[XRoT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NGfPTpdKSzVyPUeuOFM6PjdizszN MUHTRW5ITVJ?
SKG-IIIa NX\sZXlzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NGnq[HdKSzVyPUeuOFU{QDFizszN NFXVfZZUSU6JRWK=
HCC1419 NH63U3BIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MlTQTWM2OD15LkS2PFM{KM7:TR?= MkXRV2FPT0WU
OS-RC-2 MVfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MWPJR|UxRTdwNEm4PVQh|ryP M{mzdXNCVkeHUh?=
COLO-829 M3fu[2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NWriVFFZUUN3ME23MlY3PDZ|IN88US=> NGfFUG5USU6JRWK=
NB13 MVHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MoLiTWM2OD15LkiyOlY4KM7:TR?= M170b3NCVkeHUh?=
DK-MG MoLOS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NUKzTIM2UUN3ME23Mlg{OjBzIN88US=> NWfJPJhiW0GQR1XS
SHP-77 M4C5bWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NWfNOZB1UUN3ME23Mlg3PjV|IN88US=> NIfsfIhUSU6JRWK=
NCI-H661 MWPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NWr4VXA3UUN3ME24MlA2QDZ5IN88US=> MUfTRW5ITVJ?
AM-38 NIDU[2tIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MUDJR|UxRThwMU[yPEDPxE1? NIfVUlNUSU6JRWK=
VM-CUB-1 MkjVS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MVnJR|UxRThwMUewNlkh|ryP M1X0VXNCVkeHUh?=
KYSE-70 M3T4T2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NI\qTW9KSzVyPUiuNVk4PjFizszN MX;TRW5ITVJ?
5637 NWHadlhwT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NEH4b4JKSzVyPUiuN|ExPTVizszN M4L6VXNCVkeHUh?=
TGBC11TKB MkHmS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MmHYTWM2OD16LkS2NVY1KM7:TR?= M1jPcXNCVkeHUh?=
EGI-1 M335NWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M1O4fWlEPTB;OD62NFA5QCEQvF2= MoPsV2FPT0WU
D-392MG M4HxT2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MX3JR|UxRThwNk[yNVQh|ryP M1PROnNCVkeHUh?=
A673 M2\ZRmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NU[xXnA4UUN3ME24MlY4PjFzIN88US=> MnuxV2FPT0WU
COLO-792 MlLoS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NGrHbpJKSzVyPUiuO|Q6PDZizszN NEHPeXZUSU6JRWK=
NCI-H1792 NHzuNI5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M4jQXGlEPTB;OD64PFkxOyEQvF2= MlPRV2FPT0WU
LS-1034 MYPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MnLFTWM2OD16Lkm0OlUzKM7:TR?= NYnLNHBDW0GQR1XS
D-566MG NVTyUIhQT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MnL4TWM2OD17LkCxPFEh|ryP NX;wT2NNW0GQR1XS
NCI-H226 M3nhemdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MVXJR|UxRTlwMEmg{txO NYXEdlA6W0GQR1XS
ChaGo-K-1 NV[5b3pST3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MomxTWM2OD17LkGwOVc6KM7:TR?= NHHDcllUSU6JRWK=
NCI-H2228 NHrMNWlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M2TGOGlEPTB;OT6xNVA5OSEQvF2= M{TIXnNCVkeHUh?=
RPMI-8226 M3[xTGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NWfLN2piUUN3ME25MlEyOzB2IN88US=> M4\HWnNCVkeHUh?=
BFTC-909 Mof4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M1XtcWlEPTB;OT6xPFI6PyEQvF2= MUfTRW5ITVJ?
HPAF-II NFX5VlRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MoS2TWM2OD17LkKyOVE5KM7:TR?= NVnoSlF[W0GQR1XS
Capan-2 NGPNR4tIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NHy2PYFKSzVyPUmuOFAyODlizszN M2TzVnNCVkeHUh?=
IA-LM NUfVcXhUT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MkjpTWM2OD17LkSxPVY3KM7:TR?= MWDTRW5ITVJ?
KP-4 NY\Nd2p5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NWraemFQUUN3ME25MlQ5QDN6IN88US=> NFTib2tUSU6JRWK=
A101D Mn22S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MnTqTWM2OD17LkWxO|E6KM7:TR?= NHT6bYtUSU6JRWK=
EFO-21 M2rWb2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MlfpTWM2OD17LkW4O|M2KM7:TR?= MY\TRW5ITVJ?
C32 MlTJS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M{WzbWlEPTB;OT62N|M1KM7:TR?= NHjO[VdUSU6JRWK=
SW837 MoLES5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NXiyeoI6UUN3ME25Mlg1QDJizszN MV7TRW5ITVJ?
OCI-AML2 MWLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NI\uWVBKSzVyPUmuPFY6PiEQvF2= MYrTRW5ITVJ?
NCI-H1355 MnzxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NG[zRZhKSzVyPUmuPVQxQDhizszN NFW1NZlUSU6JRWK=
NCI-H2342 NEj2SopIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NETRSVJKSzVyPUGwMlAyPTVizszN NWn3dpJZW0GQR1XS
A204 NE\LZ|BIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NYnCd5JIUUN3ME2xNE4xPDZ4IN88US=> NVLuc3dnW0GQR1XS
CAL-51 M3Lye2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MUTJR|UxRTFyLkC4O|ch|ryP NGS0bYxUSU6JRWK=
HCE-4 M17qN2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NEnSPHVKSzVyPUGwMlEyOjJizszN MnftV2FPT0WU
NCI-H810 NXnmeodpT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MofZTWM2OD1zMD6xOVk4KM7:TR?= NUX2N41EW0GQR1XS
DJM-1 NGDmemZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NXz3[m1MUUN3ME2xNE4yPzN{IN88US=> NUflTItuW0GQR1XS
SK-UT-1 MUPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MnPDTWM2OD1zMD6yOVc1KM7:TR?= NH;LeYFUSU6JRWK=
U031 NVnxXVhkT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MYjJR|UxRTFyLkK2PFYh|ryP NFPHZVhUSU6JRWK=
YH-13 MkfRS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M{HyfmlEPTB;MUCuN|A2PyEQvF2= M{\KUnNCVkeHUh?=
K5 M2Lh[2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M1PIcWlEPTB;MUCuN|M6PSEQvF2= MnHZV2FPT0WU
HEC-1 M2DVW2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M3jjN2lEPTB;MUCuOFA5OSEQvF2= M4HUXXNCVkeHUh?=
A2058 MkXtS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MlHqTWM2OD1zMD61OFkyKM7:TR?= NGfhUHZUSU6JRWK=
SW962 NFnPWW5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NI\uW5JKSzVyPUGwMlYzODRizszN M{S4XHNCVkeHUh?=
VMRC-RCZ MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NGHnWY5KSzVyPUGwMlY4PDlizszN NUPKVZJZW0GQR1XS
D-336MG MoXhS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NVPoS5g6UUN3ME2xNE44ODB3IN88US=> NYrDOFd1W0GQR1XS
LXF-289 NYnXN2FrT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NWPTe|A2UUN3ME2xNE44QTZ5IN88US=> MlHoV2FPT0WU
SW900 NH\hRotIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M3jWNmlEPTB;MUCuPFIzQCEQvF2= NES1VZFUSU6JRWK=
K-562 MUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M1HKTWlEPTB;MUCuPFM6PSEQvF2= Mn;IV2FPT0WU
HCC38 MW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MkfQTWM2OD1zMD65O|E3KM7:TR?= M4[xPHNCVkeHUh?=
SF-295 MWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MY\JR|UxRTFyLkm5NFIh|ryP MmDzV2FPT0WU
LB831-BLC NHPzc|dIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NYLP[HhJUUN3ME2xNU4zPTV4IN88US=> NUXlUYVIW0GQR1XS
FTC-133 M1zCVGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NVW4cYtKUUN3ME2xNU4{ODhzIN88US=> Mn7SV2FPT0WU
HCC1954 MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NHSweoNKSzVyPUGxMlQ{PiEQvF2= MWPTRW5ITVJ?
GOTO MmLZS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MnP3TWM2OD1zMT61NlA3KM7:TR?= NFPn[nlUSU6JRWK=
LS-411N NF[zfW1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= Mo\sTWM2OD1zMT62NVAyKM7:TR?= MnPvV2FPT0WU
RPMI-7951 NUD4Wm1nT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M4rNNWlEPTB;MUGuOlM1QCEQvF2= NHrtVXpUSU6JRWK=
NCI-H1299 NIGwS5ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MoXiTWM2OD1zMT62OlQ4KM7:TR?= NIDXeIhUSU6JRWK=
MLMA MnuzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NIrkdVdKSzVyPUGxMlY6QTdizszN NILFNndUSU6JRWK=
MMAC-SF MkLZS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NHP0eW5KSzVyPUGxMlczPTJizszN MVnTRW5ITVJ?
UM-UC-3 NX3DOYVkT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MUjJR|UxRTFzLke0NlEh|ryP MknGV2FPT0WU
SCC-9 NYrDU4F3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NHf5U4RKSzVyPUGxMlgyPTFizszN MV3TRW5ITVJ?
HOS MoLpS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NUXvW|A1UUN3ME2xNU45Pjh|IN88US=> NFTQOodUSU6JRWK=
OE19 MkDZS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M1n1RmlEPTB;MUGuPVM3PyEQvF2= M{G1[nNCVkeHUh?=
Mo-T M1Tybmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NGnwNGRKSzVyPUGxMlk2PDFizszN NHzsfXZUSU6JRWK=
CAMA-1 NUHkToxjT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NEPZc5ZKSzVyPUGyMlE3OzNizszN MmrXV2FPT0WU
U-118-MG MoLjS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NF:xSHpKSzVyPUGyMlI1PDFizszN NIPiPYlUSU6JRWK=
KS-1 M3\1VWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MW\JR|UxRTF{LkK4N|Ih|ryP NELPR4xUSU6JRWK=
JAR NHfPb4ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M2jvc2lEPTB;MUKuN|M3QSEQvF2= NGj1[4JUSU6JRWK=
ABC-1 MVPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M1XPVGlEPTB;MUKuN|QyKM7:TR?= MWHTRW5ITVJ?
Daoy M2rtS2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MVPJR|UxRTF{LkS1OFIh|ryP NV65NmdwW0GQR1XS
C3A Mly0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NIjEV4pKSzVyPUGyMlU4QDVizszN M2PvVnNCVkeHUh?=
GT3TKB NH64U|FIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NESzTopKSzVyPUGyMlY{OjdizszN MmezV2FPT0WU
DMS-273 MmPYS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MoPwTWM2OD1zMj64OlM{KM7:TR?= MYPTRW5ITVJ?
G-361 MmXzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MU\JR|UxRTF{LkmxNlkh|ryP NUXxbm83W0GQR1XS
RH-18 M1;Xd2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M3XsVmlEPTB;MUOuNlk3OiEQvF2= NGDsSHhUSU6JRWK=
SN12C MmjZS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MnnOTWM2OD1zMz6zPFA5KM7:TR?= NUjRdXpKW0GQR1XS
NCI-H1993 NX3BVZhxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NFrSSWhKSzVyPUGzMlQzQDVizszN M2HZZXNCVkeHUh?=
LOXIMVI NXLVbXhKT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MYLJR|UxRTF|Lk[xOVEh|ryP NHLTfnFUSU6JRWK=
SK-PN-DW MYnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MV\JR|UxRTF|Lki0Nlch|ryP MVfTRW5ITVJ?
KALS-1 MUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M2XldWlEPTB;MUOuPFUzPSEQvF2= NIfVWWNUSU6JRWK=
LAN-6 NF;oTmZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M4T1S2lEPTB;MUSuNlU{KM7:TR?= MVnTRW5ITVJ?
A549 MX3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MUnJR|UxRTF2LkS3NVIh|ryP NIHwVmhUSU6JRWK=
RD NXPVc21lT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M4P6dmlEPTB;MUSuOFgyOyEQvF2= NXfkfHkyW0GQR1XS
TGBC1TKB MYfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? Ml;MTWM2OD1zND62OlE2KM7:TR?= M2LZN3NCVkeHUh?=
NCI-H630 NUWyVnlrT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NEPVcXJKSzVyPUG0Mlk1PjdizszN NUXxd5JyW0GQR1XS
MIA-PaCa-2 MYDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NYTsdHlnUUN3ME2xOE46PjlizszN NV;MVFBrW0GQR1XS
NCI-H1755 NUXacHVqT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MVnJR|UxRTF2Lkm5OVMh|ryP M3j6c3NCVkeHUh?=
MOLT-4 MnfES5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MVTJR|UxRTF3LkC0PVch|ryP NF64SYVUSU6JRWK=
CW-2 MXHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MlLlTWM2OD1zNT6xOFIyKM7:TR?= MYDTRW5ITVJ?
COLO-320-HSR NGO3[4JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NFn0OIRKSzVyPUG1MlU{ODdizszN NY\XbpoxW0GQR1XS
UMC-11 NVr5V41FT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M3jpbGlEPTB;MUWuO|UzOyEQvF2= Mmf4V2FPT0WU
MCF7 Mmf3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M2n2UmlEPTB;MUWuPFE1PSEQvF2= M{e2TnNCVkeHUh?=
NCI-H23 NYLHUoZ2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NF7BWpdKSzVyPUG1Mlg1OzhizszN NILGO|FUSU6JRWK=
HuCCT1 MUnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MWHJR|UxRTF3Lki3OEDPxE1? MnGwV2FPT0WU
MPP-89 M{fSWGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NVzNeGFLUUN3ME2xOU46PDF5IN88US=> Mn\IV2FPT0WU
HT55 MWjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NG\mT4xKSzVyPUG1Mlk1PzhizszN NHjWPXFUSU6JRWK=
no-11 NXnI[oQxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MmTvTWM2OD1zNT65OlY{KM7:TR?= NHOwOVJUSU6JRWK=
GP5d MoLsS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MnKxTWM2OD1zNj6yNVg4KM7:TR?= NXzNZWdGW0GQR1XS
BHT-101 MlPKS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NGHKOYRKSzVyPUG2MlI1OzlizszN MULTRW5ITVJ?
M059J MUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NGOzfW1KSzVyPUG2MlI5PCEQvF2= Mo\OV2FPT0WU
D-283MED MnXCS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MmjuTWM2OD1zNj60NlA6KM7:TR?= NVL5[IZEW0GQR1XS
BEN M4Xafmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NFLQRlJKSzVyPUG2MlUyPTVizszN MVvTRW5ITVJ?
LB373-MEL-D NEL6cm5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MUfJR|UxRTF4LkeyN|Ih|ryP NFvyZ2FUSU6JRWK=
MEL-HO NWPMZY9yT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NUnMZnN{UUN3ME2xOk45QDV2IN88US=> MW\TRW5ITVJ?
GI-ME-N M1zMOGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M4LrUWlEPTB;MU[uPVA{OiEQvF2= NV7JN5l7W0GQR1XS
RKO MnjxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NH7ifmRKSzVyPUG3MlA4PDhizszN NHLJcpZUSU6JRWK=
MZ2-MEL NWC1WlN3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M{SyVWlEPTB;MUeuNVM{KM7:TR?= M3S4R3NCVkeHUh?=
NCI-H1573 NILMWoNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MnPVTWM2OD1zNz6yPFI3KM7:TR?= MXzTRW5ITVJ?
NCI-H1581 MnPjS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MU\JR|UxRTF5LkS0NVEh|ryP NYjre4tqW0GQR1XS
NCI-H747 NF7rOZZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NHPnTohKSzVyPUG3MlUzQTdizszN NV\TXZNnW0GQR1XS
SW1783 NGPJOHdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= Mnf6TWM2OD1zNz62OFE2KM7:TR?= M2S0b3NCVkeHUh?=
Calu-6 Mme5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MYrJR|UxRTF5Lk[3PFIh|ryP MYfTRW5ITVJ?
SF268 MVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NIXV[JVKSzVyPUG3MlY6PjlizszN MVjTRW5ITVJ?
ES8 NGH3[29Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NYDoOXRuUUN3ME2xO{45PTl|IN88US=> MoLlV2FPT0WU
KM-H2 NW\YdZdQT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M4[ydmlEPTB;MUeuPVQyOSEQvF2= MYHTRW5ITVJ?
D-502MG NV;Yc4ViT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NXjmeWFNUUN3ME2xO{46QDB6IN88US=> MWXTRW5ITVJ?
HLE NEjJXohIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MlXRTWM2OD1zOD6zNVQ5KM7:TR?= NGfXXI5USU6JRWK=
SW982 Mmi1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NW\hZ3E1UUN3ME2xPE41ODd3IN88US=> M4LafnNCVkeHUh?=
MDA-MB-361 M1HrWWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NH;CTG1KSzVyPUG4MlU2QDhizszN MX\TRW5ITVJ?
NCI-H1563 MW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MWHJR|UxRTF6LkexNlQh|ryP MoLqV2FPT0WU
MFE-280 MVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MVjJR|UxRTF6LkeyPVMh|ryP NXG1S4xTW0GQR1XS
U251 NW\5fXVbT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MoTYTWM2OD1zOD63N|Q4KM7:TR?= M1rMO3NCVkeHUh?=
KNS-42 MkfhS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M2nLWWlEPTB;MUiuPFAyPSEQvF2= M{PGb3NCVkeHUh?=
U-266 MXHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MkG4TWM2OD1zOD64OlQ6KM7:TR?= MU\TRW5ITVJ?
OVCAR-8 NEf5[5BIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MVHJR|UxRTF6LkmyO|Yh|ryP M1;id3NCVkeHUh?=
MFH-ino MVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NXzYR2w2UUN3ME2xPE46PjZ7IN88US=> MmLjV2FPT0WU
D-263MG MYDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NWXnPFlkUUN3ME2xPU4xOTd{IN88US=> NH\sRWxUSU6JRWK=
NCI-H1437 NUDpZYR3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NYXpSmdpUUN3ME2xPU4xPDZ5IN88US=> MlPFV2FPT0WU
NCI-H1048 MXHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NFXyNHpKSzVyPUG5MlI{OjZizszN Ml7qV2FPT0WU
NCI-H446 MlXhS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MV;JR|UxRTF7LkO1PFkh|ryP M1TTenNCVkeHUh?=
NCI-N87 NHPrS45Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NVP3N2VlUUN3ME2xPU42QTl{IN88US=> Mn\WV2FPT0WU
WM-115 MV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NHfQNpBKSzVyPUG5MlY4PzRizszN MnLDV2FPT0WU
HuH-7 MkC4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MWLJR|UxRTF7Lke0NlEh|ryP MX3TRW5ITVJ?
NCI-H650 NUDlSGdkT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NUfI[o9JUUN3ME2xPU44PTB6IN88US=> MoLuV2FPT0WU
TYK-nu MljBS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MmXZTWM2OD1zOT64N|c5KM7:TR?= M1nWU3NCVkeHUh?=
Becker NETGO4hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MXHJR|UxRTF7Lki1OFch|ryP NUPuemw2W0GQR1XS
BB49-HNC NHrwcHJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MlL5TWM2OD1zOT65NkDPxE1? NF;YdXFUSU6JRWK=
HGC-27 MnvsS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MmDJTWM2OD1{MD6xN|k1KM7:TR?= M1nSUHNCVkeHUh?=
SiHa MmfMS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M4\ENGlEPTB;MkCuN|cyOiEQvF2= NF63PYdUSU6JRWK=
LB2518-MEL MUXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? Mn3yTWM2OD1{MD6zO|M6KM7:TR?= Mn3wV2FPT0WU
TE-5 MXfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NEnNb4dKSzVyPUKwMlc1QDJizszN NIqwfIFUSU6JRWK=
IST-SL1 M1zr[2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M{nMd2lEPTB;MkCuO|g4QSEQvF2= MnLwV2FPT0WU
A375 M2HlWmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NU[5eppnUUN3ME2yNU4xPTZ5IN88US=> NXnWT5J[W0GQR1XS
MC116 M1zXVmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MULJR|UxRTJzLkC3NlMh|ryP MlzJV2FPT0WU
GI-1 MkDWS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MoXqTWM2OD1{MT6xO{DPxE1? M1W3TnNCVkeHUh?=
HOP-62 MVPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MorlTWM2OD1{MT6yO|g1KM7:TR?= NV\h[lQzW0GQR1XS
PA-1 MWTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NITTXWJKSzVyPUKxMlI4QDdizszN NHnpendUSU6JRWK=
HT MmraS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MYTJR|UxRTJzLkSzN|Eh|ryP NEXrWmNUSU6JRWK=
HUTU-80 MWjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NFnqXJZKSzVyPUKxMlQ{OzZizszN NYr6THhiW0GQR1XS
NCI-H1975 MknRS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? Mnj5TWM2OD1{MT60OlEh|ryP M4rYWnNCVkeHUh?=
GAK NIPsbXBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M{\KRWlEPTB;MkGuOFk6KM7:TR?= MnHzV2FPT0WU
SK-N-AS M1[3cGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NFX1U5JKSzVyPUKxMlU3OTlizszN NGDDUZpUSU6JRWK=
OE33 MVrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MlK1TWM2OD1{MT62NFQ3KM7:TR?= MV;TRW5ITVJ?
YKG-1 NHG1OYlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NUTYcVdLUUN3ME2yNU43PTR3IN88US=> M3rHdnNCVkeHUh?=
CAL-85 NIXBTnFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NW\NTXY6UUN3ME2yNU46OzB3IN88US=> MULTRW5ITVJ?
NCI-H2347 NH64[JZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MXzJR|UxRTJzLkm0Nlgh|ryP NUfFNo11W0GQR1XS
PANC-08-13 NVjoVpZMT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NHfSfVBKSzVyPUKyMlAyOTlizszN MnjuV2FPT0WU
SK-N-FI MmPWS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MmiyTWM2OD1{Mj6zNFc1KM7:TR?= Ml\ZV2FPT0WU
NEC8 Ml32S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M2q1WGlEPTB;MkKuOVA4QCEQvF2= NV;3SotEW0GQR1XS
AN3-CA M4PtRWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MYPJR|UxRTJ{Lk[wPFQh|ryP NF\FOYZUSU6JRWK=
HuO9 NGLDfoRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NHHGVmNKSzVyPUKyMlc{QTZizszN MoK1V2FPT0WU
COLO-800 NFfCd4lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NET3U3NKSzVyPUKyMlc3PTNizszN NFXrUYhUSU6JRWK=
HT-29 NH7ZUY9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NG\VcmRKSzVyPUKyMlg5OjNizszN NU\2[lI4W0GQR1XS
OC-314 M37JXmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MoK0TWM2OD1{Mj64PFQ2KM7:TR?= M4DLd3NCVkeHUh?=
G-401 M3nMRWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MoXhTWM2OD1{Mz6wOFYzKM7:TR?= NEG4R5ZUSU6JRWK=
Saos-2 NVTTe|JpT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MlK4TWM2OD1{Mz61NVgzKM7:TR?= MYrTRW5ITVJ?
UACC-62 NGDmOXJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MXjJR|UxRTJ|LkW4N|Mh|ryP M1TrbnNCVkeHUh?=
D-247MG MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NULlWWUxUUN3ME2yN{44QTN7IN88US=> NYDJPG96W0GQR1XS
COLO-741 MUnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MlrvTWM2OD1{Mz65OVY2KM7:TR?= MkfjV2FPT0WU
ES3 NXKxZYk3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MknCTWM2OD1{ND6wNFI{KM7:TR?= M{Ds[3NCVkeHUh?=
LNCaP-Clone-FGC M3fjfWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NF3zS2tKSzVyPUK0MlAzOTFizszN MnTOV2FPT0WU
SW1710 NYjmfHZIT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MUnJR|UxRTJ2LkG1NFYh|ryP NIf2bmZUSU6JRWK=
LU-99A MX;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MX\JR|UxRTJ2LkG4OFEh|ryP MnHOV2FPT0WU
HOP-92 MoDMS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MYLJR|UxRTJ2LkeyOUDPxE1? MX\TRW5ITVJ?
LS-123 MnPjS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NVzEUXQ1UUN3ME2yOE46PjF2IN88US=> NWHhcVdMW0GQR1XS
T84 NXG2eoJrT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MnznTWM2OD1{ND65O|Y2KM7:TR?= MmXUV2FPT0WU
HCT-116 MmrzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? Mn7kTWM2OD1{NT60NVg3KM7:TR?= M3K2R3NCVkeHUh?=
M14 NGn3UHVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MkjLTWM2OD1{NT60OFQ4KM7:TR?= MVrTRW5ITVJ?
OCUB-M M1e3OWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M1:3Z2lEPTB;MkWuOFQ2PiEQvF2= MXzTRW5ITVJ?
MKN45 NHjsUWFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MlLBTWM2OD1{NT62N|E2KM7:TR?= NFvLdWNUSU6JRWK=
LCLC-97TM1 MVrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M17GOGlEPTB;MkWuO|I5PSEQvF2= M2jRPXNCVkeHUh?=
RVH-421 NVPH[WZvT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M{nBTWlEPTB;MkWuPFE3OSEQvF2= MXHTRW5ITVJ?
NKS-81-FD NH3lUmRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NXTlNoZ3UUN3ME2yOU46ODJzIN88US=> M2D6S3NCVkeHUh?=
NCI-H596 NVLYVI1XT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NIPuV4NKSzVyPUK2MlA1QDdizszN NYXYNJB3W0GQR1XS
GB-1 MorHS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M33l[2lEPTB;Mk[uNVg4QSEQvF2= M2O3dHNCVkeHUh?=
ZR-75-30 NXLHOIQ2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MXfJR|UxRTJ4LkKyPVch|ryP MUfTRW5ITVJ?
U-2-OS MV;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MXHJR|UxRTJ4LkO3OVch|ryP NUnKPGF{W0GQR1XS
HuP-T3 MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M3SySmlEPTB;Mk[uOlExOiEQvF2= NWr6RoJNW0GQR1XS
MOLT-16 NGTHUXBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MlS3TWM2OD1{Nj62NVY3KM7:TR?= NG\YXGVUSU6JRWK=
U-87-MG NHnTTZpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M4TtcmlEPTB;Mk[uO|Q{QCEQvF2= NX7tVo9FW0GQR1XS
8505C MXnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MXvJR|UxRTJ4LkmxNlYh|ryP MlrHV2FPT0WU
SK-MEL-3 NX\xSJZjT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MlrRTWM2OD1{Nj65PFI5KM7:TR?= MUTTRW5ITVJ?
COLO-824 NWTISVB4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NGDlb4FKSzVyPUK3MlIyQTVizszN NXrucWFHW0GQR1XS
EW-1 Mo[5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M{O3[2lEPTB;MkeuN|U2PCEQvF2= M{XVenNCVkeHUh?=
UACC-257 MVPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? Mm\DTWM2OD1{Nz6zPFA1KM7:TR?= MlvOV2FPT0WU
Hs-578-T M1;XSWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NHLnV4dKSzVyPUK3MlUzQTlizszN NVjHfoR2W0GQR1XS
UACC-893 NEDkOG9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M{fGSmlEPTB;MkeuOlY{OSEQvF2= NWXud405W0GQR1XS
MHH-NB-11 MnLOS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MULJR|UxRTJ5LkiwNFch|ryP NVf2c5hRW0GQR1XS
KYSE-410 M3\xW2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MoLXTWM2OD1{OD6yO|c6KM7:TR?= MYLTRW5ITVJ?
SF126 MVfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MYTJR|UxRTJ6Lke0N|Uh|ryP NGrxZ|lUSU6JRWK=
HT-144 MUXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NEXsUppKSzVyPUK5MlM{PjJizszN MUXTRW5ITVJ?
SW1573 M{L5eGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MUPJR|UxRTJ7LkO1NFkh|ryP MUHTRW5ITVJ?
SW620 NFTrflNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M2DyTGlEPTB;MkmuN|Y1OSEQvF2= NFXoS3JUSU6JRWK=
SCH M3z3dWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NYr0N25mUUN3ME2yPU45QDNzIN88US=> NX3oV3ZMW0GQR1XS
EW-22 MV3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NILkeWVKSzVyPUOwMlE6PjlizszN M3z1RXNCVkeHUh?=
H4 MUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MkXETWM2OD1|MD60OlU1KM7:TR?= NVG4[np2W0GQR1XS
CAS-1 M3zSWmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MmjITWM2OD1|MD63PFU6KM7:TR?= M4\WdHNCVkeHUh?=
MG-63 MWTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NEDKVIlKSzVyPUOwMlg1PzhizszN MVLTRW5ITVJ?
MDA-MB-415 NUXBSVFmT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M37qUmlEPTB;M{GuNVc2OyEQvF2= MVLTRW5ITVJ?
NCI-H1395 MlfyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M4\NbWlEPTB;M{GuNlMzQCEQvF2= M2j0PHNCVkeHUh?=
Ca-Ski NVn1boxpT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NHfYd4dKSzVyPUOxMlMyPzdizszN M174SXNCVkeHUh?=
BxPC-3 NFvkSFNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M3zIdmlEPTB;M{GuN|czQSEQvF2= NGXBeXVUSU6JRWK=
A3-KAW NGnZeJRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= Mme5TWM2OD1|MT60OFcyKM7:TR?= MUXTRW5ITVJ?
T-24 NYHzXIsxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NFuyenNKSzVyPUOxMlc{PjJizszN NHvH[IdUSU6JRWK=
NCI-H2029 NFPudGlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MnjPTWM2OD1|MT63O|Y2KM7:TR?= Mnz2V2FPT0WU
YAPC NH7RbmlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MVHJR|UxRTN{LkC0NFch|ryP M4XMNnNCVkeHUh?=
SK-MEL-2 M2nmWmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NITOdlZKSzVyPUOyMlA2OiEQvF2= NV7KRWFCW0GQR1XS
LS-513 NVXodIRqT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MYPJR|UxRTN{LkGxPFch|ryP NUnGeIppW0GQR1XS
AsPC-1 MX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MVzJR|UxRTN{LkO2NFUh|ryP NFr4PG1USU6JRWK=
KYSE-150 M1jIbWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NGnOTGFKSzVyPUOyMlM4PzNizszN NFPUVmZUSU6JRWK=
NCI-H520 NYXrXWNRT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M3W4emlEPTB;M{KuOFQ5OiEQvF2= NVn4NWVrW0GQR1XS
JEG-3 MnK4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MXrJR|UxRTN|LkC5O|Eh|ryP M4HXVHNCVkeHUh?=
GMS-10 NEfOWJdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NVzHdmJZUUN3ME2zN{4{ODB2IN88US=> M17UXnNCVkeHUh?=
HT-1080 NYTDdlFzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M4OyOWlEPTB;M{OuN|kh|ryP NV\nd3RnW0GQR1XS
NCI-H1651 NELibJJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MVTJR|UxRTN|LkO5OkDPxE1? M37DOXNCVkeHUh?=
NCI-H2122 MWTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MlnjTWM2OD1|Mz61OVc1KM7:TR?= M2fSWXNCVkeHUh?=
ES5 NFnrbWZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MoDVTWM2OD1|Mz63NlkzKM7:TR?= M{DjWnNCVkeHUh?=
8305C MWLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M33V[2lEPTB;M{OuPVk{PyEQvF2= MVLTRW5ITVJ?
KM12 MYTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NXvHR3lMUUN3ME2zOE4xPDd6IN88US=> NX\MbYxrW0GQR1XS
HCT-15 NXHKZVQzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M12wfWlEPTB;M{SuNVI4KM7:TR?= MXrTRW5ITVJ?
OVCAR-5 MWLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NEi0ZlRKSzVyPUO0MlIyQDJizszN MYDTRW5ITVJ?
NCI-H2291 NEjReWxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M2m3RWlEPTB;M{SuNlQ4OiEQvF2= MYLTRW5ITVJ?
CP50-MEL-B NIPFNZNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NVrHPFUyUUN3ME2zOE43PTl{IN88US=> NI[2OVVUSU6JRWK=
C-33-A M2TzW2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NYXIeoVjUUN3ME2zOE43QDV5IN88US=> NHLNUYdUSU6JRWK=
NCI-H2452 NFjCU5hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MlrXTWM2OD1|ND63PFgzKM7:TR?= NGTOcolUSU6JRWK=
MDA-MB-157 NGf0SoxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NITROHlKSzVyPUO0MlgyQTNizszN NYfkTXlJW0GQR1XS
LN-405 M4eyZWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NXHUZ|d6UUN3ME2zOU41OzB6IN88US=> Ml;jV2FPT0WU
MDA-MB-231 M2G3Z2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NELqcJNKSzVyPUO1MlUxPTRizszN NHW5[HZUSU6JRWK=
EW-24 MULHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NVnpbppHUUN3ME2zOU43OzN3IN88US=> Ml;DV2FPT0WU
MKN28 M4PySmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MlnXTWM2OD1|NT64NlM3KM7:TR?= MoPlV2FPT0WU
KINGS-1 NIfQcWZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NUnMbWx[UUN3ME2zOU45PDN2IN88US=> M{TtenNCVkeHUh?=
LC-2-ad MUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MmrDTWM2OD1|Nj62PVkh|ryP NGr5[5hUSU6JRWK=
IGR-1 NHLBfJVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NEjNcG5KSzVyPUO2MlcxPzVizszN MlvnV2FPT0WU
SW626 NHThO2NIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MVHJR|UxRTN5LkC0NVch|ryP MkTNV2FPT0WU
ONS-76 NHK4NopIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NWOwUnhnUUN3ME2zO{4yOzB7IN88US=> M4qyZnNCVkeHUh?=
T98G NGnnTVNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NYHuVYE4UUN3ME2zO{45PjN3IN88US=> NV7iSndUW0GQR1XS
NB14 M4PHUGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NHvzb|FKSzVyPUO4MlQ2PDRizszN MVnTRW5ITVJ?
D-423MG MkXpS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MYLJR|UxRTN6LkS4Olkh|ryP M4KwXHNCVkeHUh?=
NCI-H510A MlHnS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MWXJR|UxRTN6Lk[0OVEh|ryP NXniNmNyW0GQR1XS
NMC-G1 MmX6S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M2mwd2lEPTB;M{iuO|IzOiEQvF2= MnnGV2FPT0WU
SW948 MYTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MVHJR|UxRTN6Lki5OFkh|ryP NYf2[5hvW0GQR1XS
MFM-223 NFTQcZlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NIG1TXJKSzVyPUO4Mlk1OzFizszN MX7TRW5ITVJ?
PAN1 MVHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M1fHVmlEPTB;M{iuPVkyQSEQvF2= M2\ySnNCVkeHUh?=
MZ7-mel MnPLS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MWDJR|UxRTN7LkGxPVkh|ryP MYDTRW5ITVJ?
COLO-679 NV64S5dET3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NYnMRmJiUUN3ME2zPU46PzB6IN88US=> M2PCO3NCVkeHUh?=
SW872 MlfUS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MYXJR|UxRTRyLkKwN|Eh|ryP M4L2O3NCVkeHUh?=
HT-1197 MVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MXvJR|UxRTRyLkK4Olkh|ryP NFHCcpFUSU6JRWK=
ES6 M{XhWmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NV7ucZB6UUN3ME20NE41PTV{IN88US=> M2PKc3NCVkeHUh?=
SNU-387 M1\1NWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MmDWTWM2OD12MD64NlM5KM7:TR?= NYTMN5VnW0GQR1XS
T47D M3LYTGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MojnTWM2OD12MT6wNVkzKM7:TR?= MmPUV2FPT0WU
G-402 M1vxdWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MU\JR|UxRTRzLkC4NFkh|ryP MoeyV2FPT0WU
MZ1-PC M1LoTmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MnjBTWM2OD12MT64NUDPxE1? MYjTRW5ITVJ?
SW1417 MoL2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NVfqenZlUUN3ME20Nk4{ODNizszN Mnm0V2FPT0WU
RERF-LC-MS NWfFVmVtT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MlPJTWM2OD12Mj61NFg4KM7:TR?= MoDyV2FPT0WU
SF539 M4f1dWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NVfHZpVlUUN3ME20Nk42PTJ7IN88US=> MV3TRW5ITVJ?
ESS-1 Ml64S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MVPJR|UxRTR|LkW1OVgh|ryP NIfjPVNUSU6JRWK=
RO82-W-1 M1X6bmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Ml3YTWM2OD12Mz62NVU{KM7:TR?= NV7ySWhZW0GQR1XS
S-117 MXPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MYHJR|UxRTR|Lk[5OVgh|ryP Mln3V2FPT0WU
SW756 MVLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MlL2TWM2OD12Mz64NlQzKM7:TR?= M2jT[nNCVkeHUh?=
CP66-MEL M136cmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NXLtbY9JUUN3ME20OU44OTR|IN88US=> NV3MfWl5W0GQR1XS
H-EMC-SS NHWzZ2ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NG[xXZZKSzVyPUS1Mlc3QTNizszN MX3TRW5ITVJ?
NCI-H2052 Mnq2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? Ml3mTWM2OD12NT65NFI4KM7:TR?= MlfOV2FPT0WU
SW684 MnexS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MlzQTWM2OD12Nz6wNFgyKM7:TR?= Mm\QV2FPT0WU
HCC1569 NHX5VG9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NIrWblNKSzVyPUS3MlE3PThizszN MnTCV2FPT0WU
KGN NU\seGVFT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NF7lSGtKSzVyPUS3MlM{OTFizszN NYnEco5zW0GQR1XS
LCLC-103H M1P6b2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NI\WU5BKSzVyPUS3MlQ1ODRizszN M4K0XXNCVkeHUh?=
SW780 M16xUmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MoGyTWM2OD12Nz62N|UyKM7:TR?= NX;pSJdNW0GQR1XS
NCI-H1703 MX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M{TjcmlEPTB;NEiuN|M2OiEQvF2= MXfTRW5ITVJ?
HCC1395 NXLte21bT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MVfJR|UxRTR6Lke0N|Ih|ryP NYHPVmhOW0GQR1XS

... Click to View More Cell Line Experimental Data

In vivo Gefitinib (100 mg/kg) improves the anti-tumor effect of radiotherapy in LoVo tumor xenografts. [3] Gefitinib treatment of nude mice bearing established human GEO colon cancer xenografts reveals a reversible dose-dependent inhibition of tumor growth because GEO tumors resumes the growth rate of controls at the end of the treatment. [4]

Protocol

Cell Research
+ Expand
  • Cell lines: NR6, NR6M and NR6W cells
  • Concentrations: 0-2 μM
  • Incubation Time: 72 hours
  • Method: Exponentially growing cells including NR6, NR6M, NR6M and NR6W cells are seeded in sextuple in 96-well plates at a concentration of 2000 cells/well, allowed to adhere and subsequently washed in PBS and incubated overnight in medium containing 0.5% FCS. Cells are then treated with varying concentrations (0-2 μM) of Gefitinib or the solute control DMSO and EGF. The optimal EGF concentration for inducing proliferation of NR6wtEGFR and NR6W cells has previously been determined and hence NR6wtEGFR and NR6W cells are supplemented with 10 nM and 0.1 nM EGF, respectively. EGF is not added to NR6 and NR6M cells. After 72 hours the amount of cells are measured by performing a MTT proliferation assay.
    (Only for Reference)
Animal Research
+ Expand
  • Animal Models: Female nude mice (cba nu/nu) aged 8–10 weeks are intra-dermal injected with LoVo cells.
  • Formulation: 0.5% polysorbate
  • Dosages: 100 mg/kg
  • Administration: Once daily by oral administration (0.1 mL/10 g body weight) for 14 days
    (Only for Reference)

Solubility (25°C)

In vitro DMSO 89 mg/mL (199.14 mM)
Ethanol 4 mg/mL (8.95 mM)
Water <1 mg/mL
In vivo 5% DMSO+corn oil 2.5mg/mL

* 1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Chemical Information

Molecular Weight 446.90
Formula

C22H24ClFN4O3

CAS No. 184475-35-2
Storage powder
in solvent
Synonyms N/A

Bio Calculators

Molarity Calculator

Molarity Calculator

Calculate the mass, volume or concentration required for a solution. The Selleck molarity calculator is based on the following equation:

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

  • Mass
    Concentration
    Volume
    Molecular Weight

*When preparing stock solutions, please always use the batch-specific molecular weight of the product found on the via label and MSDS / COA (available on product pages).

Dilution Calculator

Dilution Calculator

Calculate the dilution required to prepare a stock solution. The Selleck dilution calculator is based on the following equation:

Concentration (start) x Volume (start) = Concentration (final) x Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2 ( Input Output )

  • C1
    V1
    C2
    V2

* When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and MSDS / COA (available online).

The Serial Dilution Calculator Equation

  • Serial Dilutions

  • Computed Result

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):
Molecular Weight Calculator

Molecular Weight Calculator

Enter the chemical formula of a compound to calculate its molar mass and elemental composition:

Total Molecular Weight: g/mol

Tip: Chemical formula is case sensitive. C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:

To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.

Definitions of molecular mass, molecular weight, molar mass and molar weight:

Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Clinical Trial Information

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT02836847 Recruiting Cholangiocarcinoma of the Extrahepatic Bile Duct|Gallbladder Cancer Shanghai Jiao Tong University School of Medicine|Xinhua Hospital, Shanghai Jiao Tong University School of Medicine|Ruijin Hospital|RenJi Hospital|Eastern Hepatobiliary Surgery Hospital|Huashan Hospital July 2016 Phase 2
NCT02824458 Recruiting EGFR Tyrosine Kinase Inhibitors Plus VEGFR Inhibitors Sun Yat-sen University June 2016 Phase 3
NCT02740894 Completed Is Targeted Therapy Increasing Survival Inoperable Nonsmall Cell Lung Cancer With Spinal Metastasis ? Taipei Veterans General Hospital, Taiwan February 2016 --
NCT02347839 Recruiting Lung Cancer Sun Yat-sen University January 2016 Phase 2
NCT02588261 Recruiting Non-small Cell Lung Cancer (NSCLC) Astellas Pharma Global Development, Inc.|Astellas Pharma Inc November 2015 Phase 3
NCT02326285 Recruiting Non-squamous Non-small Cell Lung Cancer Stage II|Non-squamous Non-small Cell Lung Cancer Stage IIIA|Non-squamous Non-small Cell Lung Cancer Stage IIIB|Activating EGFR Mutation|NSCLC AIO-Studien-gGmbH|AstraZeneca November 2015 Phase 2|Phase 3

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

  • * Indicates a Required Field

Frequently Asked Questions

  • Question 1:

    I try to dissolve Gefitinib (ZD1839) in 0.5% methylcellulose+0.2% Tween 80 for in vivo experiments. However, when I prepare the mixture, it forms precipitates. Exists another way to dissolve completely the compound?

  • Answer:

    S1025 can be dissovled in both 5% DMSO+corn oil and 5% DMSO+30% PEG 300+5% Tween 80+ddH2O at 2.5 mg/ml clearly. It dissolves in DMSO not readily, please sonicate and warm it in water bath at about 45 degree, and dissolve it clearly first. Then add other solvent.

EGFR Signaling Pathway Map

EGFR Inhibitors with Unique Features

Related EGFR Products

Tags: buy Gefitinib (ZD1839) | Gefitinib (ZD1839) supplier | purchase Gefitinib (ZD1839) | Gefitinib (ZD1839) cost | Gefitinib (ZD1839) manufacturer | order Gefitinib (ZD1839) | Gefitinib (ZD1839) distributor
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID